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The cytoplasmic dynein motor protein complex transports a number of different important cargos 
along microtubules (MTs) in a retrograde manner.  Cytoplasmic dynein plays an important role 
in many cellular processes and a number of diseases have been associated with defects in its 
activity. Despite its importance, there are no small molecules that selectively modulate 
cytoplasmic dynein activity, nor is its atomic structure elucidated.  In an effort to identify 
compounds that target cytoplasmic dynein, hits from a high information content cell-based 
nuclear translocation assay were further evaluated biochemically.  High throughput assays were 
developed to screen for glucocorticoid ligand competition, MT perturbation, and the ATPase 
activities of Hsp 70 and 90, cytoplasmic dynein heavy chain 1, and myosin.  Several compounds 
from screening the Library of Pharmacologically Active Compounds (LOPAC1280) were 
identified to inhibit cytoplasmic dynein, though they had several unattractive pharmacological 
properties and were generally non-specific.  Additional screening of the Molecular Libraries 
Screening Center Network >220,000-member library showed a number of compounds that 
specifically inhibited the ATPase activity of cytoplasmic dynein heavy chain 1 with little or no 
interaction with other proteins involved in cargo complex formation.  A novel approach to screen 
for MT perturbing agents was also developed using biosensors.  Thickness, mass, and density 
measurements from dual polarization interferometry suggested the growth process of MTs on 
BIOPHYSICAL AND PHARMACOLOGICAL CHARACTERIZATION OF 
CYTOPLASMIC DYNEIN HEAVY CHAIN 1  
 
Hikmat N. Daghestani, Ph.D. 
University of Pittsburgh, 2010
 
 v 
surfaces.  Resonant mirror biosensors were used to distinguish MT stabilizers from destabilizers 
based on rates of MT assembly on the surfaces. 
In addition, the structure of the cytoplasmic dynein heavy chain motor domain was 
characterized by computational and experimental methods.  Comparative homology structural 
modeling was used to predict 15 surface accessible cysteines, which were then correlated 
experimentally by mass spectrometry.  Five cysteines were matched computationally and 
experimentally to be surface-accessible, suggesting some inadequacy of the proposed model. 
 Finally, attempts to reconstruct a model of cytoplasmic dynein heavy chain 1 by electron 
microscopy were hindered by the purification of the protein from both a Hi5/baculovirus 
expression system and bovine brain, although the latter appeared to provide better quality 
micrographs.  Ultimately, structural characterization will assist with the discovery of cytoplasmic 
dynein heavy chain 1 modulators. 
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1.0  INTRODUCTION 
1.1 EUKARYOTIC CYTOSKELETAL STRUCTURE & INTRACELLULAR 
TRANSPORT 
1.1.1 Cytoskeleton 
The cell is a highly organized system consisting of multiple components that serve different roles 
in cell development and function.  The component that provides the cell its mechanical strength 
and mobility is called the cytoskeleton – a system of protein filaments that interacts with other 
proteins in the cytoplasm.  The cytoskeleton plays several other important roles such as pulling 
apart the chromosomes during mitosis (Tolic-Norrelykke, 2008), providing pathways for cargos 
to shuttle across the cell (Vale, 2003), and providing the mechanical force of flagellar systems to 
propel through the cytoplasm (Misamore and Lynn, 2000).  These functions depend on the 
organization of three main types of filaments: microtubules, microfilaments, and intermediate 
filaments.  
1.1.1.1 Microtubules 
Microtubules (MTs) are formed from the assembly of tubulin protein.  Tubulin in its soluble 
form is a heterodimer of tightly bound α and β isotypes (Burns, 1991).  Both isotypes are 
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globular proteins with molecular weight of ca. 50 kDa that share approximately 40% sequence 
identity and are almost identical in structure (Downing and Nogales, 1998).  Each monomer has 
a nucleotide binding site, which lies at the interface between the two monomers.  As a result, 
guanosine triphosphate (GTP) bound to the α subunit is shielded in a non-exchangeable manner, 
while GTP bound to the β subunit is partially exposed and can hydrolyze to guanosine 
diphosphate (GDP) (MacNeil and Purich, 1978; Downing and Nogales, 1998).  Tubulin 
heterodimers assemble vertically to form protofilaments.  Protofilaments have directionality, 
with the α subunit pointing towards the minus (–) end and the β subunit pointing towards the 
plus (+) end.  Approximately 13 protofilaments join laterally in a three-start left-handed helix to 
form a hollow tube that is ~25 nm in diameter, the MT (Wade and Chretien, 1993; Chretien and 
Fuller, 2000) depicted in Figure 1.  
 
Figure 1. Structure of Tubulin/Microtubules 
(A) Crystal structure cartoon of a tubulin heterodimer consisting of α and β subunits, each possessing a 
GTP binding site.  (B) Heterodimers stack vertically to form the protofilament with the α subunit towards the minus 
end and the β subunit towards the plus end.  (C) Approximately 13 protofilaments join laterally in a three-start left 
handed helix to form a hollow tube called the microtubule. Figure ©2008 from Molecular Biology of the Cell 5E by 
Alberts et al. Reproduced by permission of Garland Science/Taylor and Francis.  
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The process of MT formation begins with the slow association of soluble heterodimers to 
begin the nucleation process (Figure 2).  Following this phase, protofilament elongation and 
subsequent formation of the MT will occur at a greater rate until the MT reaches a steady state 
assembly and disassembly rate (Voter and Erickson, 1984).  The presence of GTP plays an 
important role in the stability of the MT; heterodimers GDP bound to heterodimers tends to 
make MTs unstable and, therefore, prone to disassembly (MacNeil and Purich, 1978).  MTs are 
an important component of the cell, providing cells with a scaffold for signaling proteins, as well 
as a railway for molecular motor proteins to perform their trafficking duties.  MTs are also an 
essential component of the mitotic spindle, the apparatus that segregates sister chromatid pairs 
during cell division (Jordan and Wilson, 1998).  These roles are a function of microtubule 
dynamics (Saxton et al., 1984), the relative rates of assembly (growth or rescue) and disassembly 
(shrinkage or catastrophe) at both the plus and minus ends of the MTs.  These dynamics are also 
regulated by the interaction of a number of different microtubule associated proteins (MAPs), 
which can either stabilize (e.g., MAP2) (Gamblin et al., 1996) or destabilize (e.g., stathmin) 
(Cassimeris, 2002) the MT.  
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Figure 2. Microtubule Dynamics 
The association of GTP-bound tubulin to MTs will cause the MT to polymerize or grow.  Upon hydrolysis 
of GTP on the β subunit to GDP, protofilaments and tubulin heterodimers will dissociate from the MT causing MT 
depolymerization or shrinkage.  The transition between MT depolymerization to polymerization is called rescue and 
the reverse transition is termed catastrophe [adapted from Conde and Caceres, 2009 with permission from 
publisher].  
1.1.1.2 Microfilaments 
Actin, like tubulin, exists as a globular protein termed G-actin, which assembles linearly to form 
a helical filamentous polymer called F-actin or microfilaments (MF) that are approximately 9 nm 
in diameter (Figure 3) (Dos Remedios et al., 2003).  Actin polymerization takes place in the 
presence of ATP, Mg2+ and K+ and similarly to MTs, the hydrolysis of ATP to its respective 
diphosphate and subsequent release of ADP will cause the MF to depolymerize (Korn et al., 
1987).  Also similarly to MTs, MFs possess polarity, causing the MF to increase in length in a 
specific direction (Kirschner, 1980).  This property allows the MF to treadmill in a particular 
direction and is therefore responsible for cell movement (Theriot and Mitchison, 1991; Pollard 
and Borisy, 2003).  An actin associated protein called filamin will crosslink MFs with each other 
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to increase the strength and rigidity of MFs (Goldman et al., 1997).  Filamin also links the actin 
cytoskeleton to the cell membrane by binding to transmembrane proteins (Calderwood et al., 
2001).  In order for cells to avoid overstretching during cell movement, actin filaments are 
depolymerized via severing proteins such as gelsolin (McGough et al., 2003) and cofilin (Pavlov 
et al., 2007).   
 
Figure 3. Structure of Actin/Microfilaments 
(A) Crystal structure cartoon of an actin protein.  (B) Actin molecules will form linear filaments that 
intertwine into a helical filament polymer known as the microfilament. Figure ©2008 from Molecular Biology of the 
Cell 5E by Alberts et al. Reproduced by permission of Garland Science/Taylor and Francis. 
1.1.1.3 Intermediate Filaments 
Intermediate filaments (IFs) are formed from the non-covalent assembly of a large family of rod 
like-proteins, giving rise to a wide variety of IFs such as keratins and lamins to name a few 
(Herrmann et al., 2007).  The term IF stems from the intermediate size of filaments in 
comparison to MTs and MFs, averaging around 10 nm in diamter (Fuchs and Weber, 1994).  The 
alpha-helical rod domains from two proteins intertwined like a rope, forming either a homodimer 
or heterodimer, which then line up head-to-tail in a staggered confirmation to form the filaments 
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(Figure 4) (Fuchs and Weber, 1994).  Unlike MTs or MFs, IFs do not require binding and 
subsequent hydrolysis of a nucleotide (Angelides et al., 1989).  These filaments do not exhibit 
the same nucleotide-dependent dynamic properties as the other two cytoskeletal structures nor do 
they possess a polarity.  IFs are very tensile and are primarily responsible for providing the cell 
with a great amount of strength (Goldman et al., 2008).  
 
Figure 4. Structure of Intermediate Filaments 
(A) A monomeric cartoon of a rod-like protein that forms the basis of intermediate filaments.  (B) A coiled-
coil dimer is formed between two monomers.  (C) Dimers will non-covalently bind with each other forming 
tetramers.  (D) Tetramers continue to associate with each other forming intermediate filaments. Figure ©2008 from 
Molecular Biology of the Cell 5E by Alberts et al. Reproduced by permission of Garland Science/Taylor and 
Francis.  
1.1.2 Cytoskeletal Motor Proteins 
1.1.2.1 Cytoplasmic Dynein 
Cytoplasmic dynein is a large multi-protein complex amassing to ~ 1.2 MDa that translocates 
along MTs retrogradely (i.e., towards the minus end of MTs) (Paschal et al., 1987; Vale, 2003; 
Vallee et al., 2004).  The dynein complex consists of a heterodimer of large (~ 530 kDa), 
globular heavy chains that contain the motor domain, and pairs of intermediate, light 
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intermediate and light chains that are associated with subcellular localization, MT recognition, 
and cargo binding as depicted in Figure 5 (Vale, 2003).  The dynein motor is a ring-like 
structure, consistent with proteins from the AAA (ATPases associated with diverse cellular 
activities) family, consisting of six AAA domains and a seventh domain, protruding between 
AAA modules 4 and 5 (King, 2000).  This latter domain leads to the ~10-15 nm coiled-coil stalk, 
which recognizes and binds MTs through a MT-binding domain (MTBD) (Mizuno et al., 2007).  
The first four AAA domains possess phosphate binding loop (P-loop) motifs necessary for 
nucleotide binding, which provides the AAA domains the ability to hydrolyze ATP (Asai and 
Koonce, 2001).  Conformational changes due to the ATP hydrolysis from the first AAA domain 
is responsible for motor function while the other three domains are believed to have regulatory 
roles (e.g., increasing the rate of MT movement driven by dynein) (Reck-Peterson and Vale, 
2004; Cho et al., 2008). Conformational changes have also been observed with other AAA 
proteins upon nucleotide binding, hydrolysis and release (Mocz and Gibbons, 2001; Burgess et 
al., 2003).  
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Figure 5. Structural Model of Cytoplasmic Dynein 
A proposed cartoon model of cytoplasmic dynein showing a pair of heavy, light-intermediate, intermediate, 
and light chains.  The heavy chain consists of a central ring motor domain with a protruding coiled-coil stalk that 
leads to a MT binding domain.  The heavy chain also possesses a stalk domain that interacts with the other chains of 
cytoplasmic domain [adapted from Vale, 2003 with permission from publisher].  
 
The intermediate chains connect the motor domain to a complex of proteins that is 
deemed the cargo. Proteins transported by cytoplasmic dynein are linked through dynactin (Gill 
et al., 1991; Holleran et al., 1998) and immunophilin-heat shock protein complexes (Galigniana 
et al., 2004). Such cargos can vary from large Golgi vesicles (Corthesy-Theulaz et al., 1992) and 
viruses (Dohner et al., 2002; McDonald et al., 2002) to smaller proteins such as the tumor 
suppressor p53 (Galigniana et al., 2004) or even nuclear hormone receptors such GR 
Electron micrograph images of cytoplasmic dynein in different ATP-transition states 
have provided insights into the mechanism of cytoplasmic dynein translocation along MTs 
(Burgess et al., 2003).  The only structural information about cytoplasmic dynein, however, is 
based on low-resolution (~25 Å) negative stain electron microscopy images (Samso and Koonce, 
(Harrell et 
al., 2004).   
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2004) and a recent cryoelectron microscopy structure of cytoplasmic dynein bound to MTs 
(Mizuno et al., 2007).  Other research groups have added green-fluorescent protein (GFP) tags to 
cytoplasmic dynein’s motor domain in order to assist with mapping the domains from negative 
stain electron micrographs (Roberts et al, 2009).  In addition, a number of groups have attempted 
to build models of cytoplasmic dynein based on homology with other AAA proteins (Figure 6) 
(Mocz and Gibbons, 2001; Serohijus et al., 2006), yet these models do not necessarily 
correspond well to electron microscopy images.  Despite all these attempts, a clear atomic 
resolution structure of cytoplasmic dynein is yet to be achieved.  
 
Figure 6. Computational Models of Cytoplasmic Dynein Motor Domain 
(A) Structural model of cytoplasmic dynein motor domain based on sequence homology of hexameric 
AAA proteins proposed by Mocz and Gibbons, 2001.  (B) Comparative structural homology model of cytoplasmic 
dynein motor domain based on crystal structures of proteins with sequence homologies of domains within motor 
domain proposed by Serohijus et al., 2006.  
1.1.2.2 Kinesin 
Kinesin is another molecular motor that utilizes the energy harvested from ATP to transport 
cargo along MTs, but predominantly in an anterograde manner (Hirokawa et al., 1991) with the 
exception of the Kinesin-14 family (Ambrose et al., 2005).  Kinesin is smaller (~ 100-200 kDa) 
than dynein and has very little similarity in structure, consisting of a dimer of heavy and light 
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chain dimers (Figure 7).  The heavy chain motor domain has been previously crystallized (Kull 
et al., 1996) whose structure is depicted as a globular protein with a P-loop motif that is capable 
of MT binding.  A long (~ 70 nm) coiled-coil stalk facilitates dimerization and links the heavy 
chains to the light chains where cargos bind to kinesin (Gennerich and Vale, 2009).  The kinesins 
consist of a relatively large family of motor proteins that vary in length and size that can be 
found in monomeric, dimeric, tetrameric, and heterotrimeric forms (Hirokawa, 1998), with 
conventional kinesin being the most abundant in the nervous system (Wagner et al., 1991). 
 
Figure 7. Structural Model of Kinesin 
A cartoon model of conventional kinesin showing a pair of heavy and light chains.  The heavy chain 
consists of a globular motor domain that binds and hydrolyzes ATP to produce the energy needed to translocate 
along MTs.  The heavy chain also directly binds to MTs.  A long (~70 nm) coiled-coil filament connects the heavy 
chains to the light chains, where cargo binding takes place [adapted from Vale, 2003 with permission from 
publisher]. 
 
Kinesin has been shown to mediate MT-MT interactions and MT bundling (Straube et 
al., 2006).   As with dynein, kinesin transports a number of different cargos including organelles 
(Hirokawa, 1998), scaffolding proteins (Verhey et al., 2001), the amyloid precursor protein 
involved in Alzheimer’s disease (Kamal et al., 2000), and is involved in chromosome 
segregation (Barton and Goldstein, 1996).  
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1.1.2.3 Myosin 
Myosin is a large family of motor proteins that uses ATPase activity to translocate along MFs 
rather than MTs.  Although myosin and kinesin do not share any sequence homology, their 
structures are very similar (Kull et al., 1996) based on crystal structures of the motor or head 
domain.  Similar to kinesin, ATP binding and hydrolysis occur at the motor domain and the 
motor domain directly interacts with microfilaments.  In addition, myosin has a coiled-coil 
filament, termed the light chain, which mainly dimerizes two heavy chains and also directly 
binds to various cellular targets (Figure 8).  Myosin translocation is generally directed towards 
the plus (+) end of actin filaments with the exception of myosin VI, which uniquely translocates 
towards the minus (–) end of actin filaments (Rodriguez and Cheney, 2000). 
 
Figure 8. Structural Model of Myosin 
A cartoon model of myosin showing a pair of heavy, light-intermediate, intermediate, and light chains.  The 
heavy chain consists of a central ring motor domain with a protruding coiled-coil stalk that leads to a MT binding 
domain.  The heavy chain also possesses a stalk domain that interacts with the other chains of cytoplasmic domain 
[adapted from Vale, 2003 with permission from publisher]. 
 
Myosin, along with MFs, is responsible for important processes involved at the leading 
edge of migrating cells (Chibalina et al., 2009).  Myosin is also responsible for vesicle transport 
and signal transduction (Mermall et al., 1998), golgi transport (Ikonen et al., 1997), and is 
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believed to play a role in cytokinesis following mitotic spindle signaling events (Matsumura, 
2005).  Myosin also transports mitochondria in axons, but there is evidence that mitochondria are 
also transported bidirectionally along MTs through interactions with both kinesin and dynein 
(Hollenbeck and Saxton, 2005). 
1.2 SIGNIFICANCE 
1.2.1 Microtubule Perturbing Agents as Cancer Therapeutics 
With MTs playing an important role in cell structure and function, it is not surprising that defects 
in MT organization are associated with diseases such as the increased MT dynamics observed in 
cancer cells (Jordan and Wilson, 2004).  There are many MT-stabilizing and -destabilizing drugs 
that have been demonstrated to suppress cancer growth and cause cell death (Jordan and Wilson, 
2004).  For example, paclitaxel (PTX; Taxol®) (Figure 9), a known natural product derived from 
the bark of Pacific yew (Taxus brevifolia) trees, is commonly used in the clinic to treat solid 
tumors (Rowinsky and Donehower, 1995) and has been demonstrated to stabilize MTs (Kumar, 
1981), even in the absence of GTP (Howard and Timasheff, 1998).  Other drugs used to treat 
cancer include the MT stabilizer epothilone B (Hamel, 2003), while other products such as 
dolastatin 10 (Hamel, 1992) and colchicine (Bhattacharyya, 2008) have a negative effect on MTs 
by destabilizing their formation.  As many of the current anticancer drugs have undesired 
toxicities, and/or cancer cells may become resistant to such drugs by increasing expression of 
multidrug resistance-associated proteins (Drukman and Kavallaris, 2002; Kavallaris, 2010), it is, 
therefore, critical to screen for other agents and mixtures of agents that perturb MTs, but with 
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fewer undesired toxicities.  The structural changes that take place upon binding of MT-
perturbing agents to tubulin vary with the type and location of tubulin binding (Sackett, 1995).  
An important step towards understanding the mechanism of such compounds depends on 
detecting the structural changes that take place upon binding.   
 
Figure 9. Chemical Structures of Microtubule Perturbing Agents 
(A) Paclitaxel, a MT stabilizer.  (B) Epothilone B, a MT stabilizer.  (C) Colchicine, a MT destabilizer.  (D) 
Dolastatin 10, a MT destabilizer.  
1.2.2 Potential use of Dynein Activators/Inhibitors 
Through interactions with the intermediate chains, immunophilins link important cargo, such as 
the tumor suppressor p53, to the Hsp90 chaperone complex and bind to cytoplasmic dynein 
(Galigniana et al., 2004).  Dynein then translocates the attached cargo to the nucleus where the 
tumor suppressor p53 transcriptional factor can activate genes in response to DNA damage (Liu 
and Kulesz-Martin, 2001).  Cytoplasmic dynein also contributes to many important cellular 
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functions such as providing the force needed in nuclear envelope breakdown (Salina et al., 2002), 
chromosome segregation (Sharp et al., 2000), mitotic spindle formation 
Increased expression of cytoplasmic dynein light chain 1 has been associated with the 
acceleration of the G1/S transition and breast tumorigenesis (den Hollander and Kumar, 2006; 
Vadlamudi et al., 2004).  Additional information suggests that the cytoplasmic dynein light chain 
is a co-activator for estrogen receptor (ER) transactivation in breast cancer cells (Rayala et al., 
2005).  Since cytoplasmic dynein’s light chain 1 associates with the heavy chain 1 motor domain 
along with the apparent role of the light chain in breast cancer, inhibiting the motor domain can 
be a potential target for anti-cancer drugs.  Similarly, there have been implications in the 
literature that motor protein inhibitors such as monastrol, which inhibits kinesin motor activity, 
can be used to target and kill cancer cells (Wacker and Kapoor, 2010).  
(Vaisberg et al., 1993), 
and cytokinesis (Yeh et al., 1995). 
Moreover, defects in cytoplasmic dynein have implications in neurodegenerative 
diseases.  Lissencephaly, a devastating neurological disorder characterized by decreased brain 
folds and the development of smaller than usual brain sizes (Wynshaw-Boris and Gambello, 
2001), like several other neuronal disorders, is associated with malfunctions in neuronal 
migration (Mesngon et al., 2009).  A number of genetic studies have pointed to the LIS1 gene as 
the cause for lissencephaly as well as other neuronal migration disorders (Smith et al., 2000).  
LIS1 is believed to associate with and regulate the function of cytoplasmic dynein in neuronal 
movement (Smith et al., 2000).   Other disorders such as amyotrophic lateral sclerosis (ALS) and 
spinal muscle atrophy are also associated with deterioration of motor neurons, which disrupts 
axonal retrograde transport mediated by dynein, while mutations in dynein or dynactin exhibit 
similar phenotypic characteristics as the abovementioned disorders (Bartlett et al., 1998; 
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LaMonte et al., 2002; Ateh et al., 2008; Banks and Fisher, 2008).  This highlights the importance 
of targeting cytoplasmic dynein with chemical biology tools (inhibitors and activators) to study 
the mechanism of neurodegenerative diseases associated with neuronal motor function.  With 
cytoplasmic dynein’s apparent role in neuronal migration and neurological disorders, it is 
important to understand the structure of cytoplasmic dynein and how conformational changes 
effect its mechanism of action. 
To date, there are only a handful of small molecules that target cytoplasmic dynein, most 
of which are either ATP/transition state mimics (e.g., EHNA, AMP-PNP, orthovanadate) 
(Bouchard et al., 1981; Vallee and Shpetner, 1990) or sulfhydryl-reactive agents (e.g., thiourea 
and N-ethylmaleimide (NEM)) (Blum et al., 1979; Vallee and Shpetner, 1990) (Figure 10).  The 
Day lab previously examined purealin, a natural product derived from the sea sponge 
Psammaplysilla purea, that has been shown enhance the ATPase activity of myosin (Takito et 
al., 1986) while also inhibiting the ATPase activity of axonemal dynein (Fang et al., 1997).  
Synthetic analogues of purealin inhibited the ATPase activity of rat cytoplasmic dyenin heavy 
chain 1 (Zhu et al., 2006).  Although purealin itself was a potent inhibitor of cytoplasmic dynein 
heavy chain in vitro, the compound was unable to do so in cells.  Purealin as well as other 
compounds that have been recently screened in the Day lab are of specific interest because they 
are not ATP mimics and do not compete with ATP binding to the dynein motor.  This is 
important because such uncompetitive inhibitors (Nelson and Cox, 2005) can potentially increase 
the specificity of targeting only cytoplasmic dynein rather than inhibiting other important ATP-
dependent proteins such as those from the Hsp family (Rowlands et al., 2004).  Understanding 
how purealin and other agents inhibit cytoplasmic dynein’s motor activity is an important step 
towards identifying other more selective inhibitors.  Because of the many important roles in 
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which cytoplasmic dynein participates, small molecule inhibitors of dynein could be useful as 
chemical and cell biology tools.  
 
Figure 10. Chemical Structures of Cytoplasmic Dynein Inhibitors 
(A) N-Ethylmaleimide (NEM), a sulfhydryl reactive reagent.  (B) Orthovanadate, a phosphate analog.  (C) 
erythro-9-(2-Hydroxy-3-nonyl)adenine) (EHNA), an ATP mimetic.  (D) Purealin, a natural product derived from the 
sea sponge Psammaplysilla purea known to enhance the ATPase activity of myosin, while also inhibiting both 
axonemal and cytoplasmic dynein in vitro. 
1.3 BIOPHYSICAL TOOLS 
Understanding the particular role of a given protein and how it relates to disease is an important 
step in treating the disease.  Identifying the structure of a protein is one of the most important 
steps at understanding the function, followed by a number of biochemical assays.  Many 
biophysical techniques have been used extensively to elucidate the structures of macromolecules.  
Here I will discuss the basic principles behind some of the techniques used to shed light towards 
the structure and function of cytoplasmic dynein heavy chain 1.    
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1.3.1 Computational Modeling 
A large part of understanding the roles and functions of biological systems involves visualizing 
the molecular interactions that take place between proteins.  More recently, advances in 
biophysical techniques has allowed for greater resolution of data collected, along with the 
assistance and supplementation of computational modeling and data fitting.  Since experimental 
techniques often have limitations, most commonly due to size constraints, computational 
modeling can assist with the prediction of three-dimensional protein structures.  Computational 
prediction is particularly useful in generating comparative homology models of a protein with 
unknown experimental structure by comparison with known structures of proteins of shared 
sequence homology.  There are several computer programs and web servers that use different 
algorithms to generate such data.  For example, MODELLER is a program used for comparative 
homology modeling that, like many other programs, follows four main steps: fold assignment, 
target-template alignment, model building, and model evaluation (Marti-Renom, 2000).  
Comparative homology modeling begins by searching protein data bank (PDB) structures of 
proteins with high sequence homology (template) to the protein sequence of interest (target).  
Model building is based on dissecting template PDB structures into smaller conserved core 
regions followed by aligning and superimposing portions of the target sequence into these core 
structures (Blundell et al., 1987) and using distance and dihedral angle restraints (Sali and 
Overington, 1994).  Loops to connect the core domains with each other are generated by 
scanning a broader subset of PDB structures that connect similar core structures to each other 
(Topham et al., 1993).  Amino acid side chains are then modeled to fit their intrinsic 
conformation properties and based on the orientation of side chains from the template structure 
(Sutcliffe et al., 1987).  Finally, the 3D model is evaluated by the stereochemistry (bond length, 
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bond angle, chirality, side chain torsion angles, clashes between nonbonded pairs of atoms, etc.) 
based on statistical potentials of mean force profiles (Sippl, 1990).  Performing a number of 
iterative model building and evaluation steps generally optimizes final 3D models and 
experimental data is often used to supplement model constraints (Eswar et al., 2007). 
1.3.2 Mass Spectrometry 
Mass spectrometry (MS) is an analytical tool that is used to decipher the composition of 
chemicals and peptides.  The technique is often associated with genomic and proteomic 
mapping, but has applications in structural biology and drug discovery.  The principle behind MS 
involves detecting the mass-to-charge (m/z) ratio of chemical fragments of the molecule of 
interest.  Chemical fragmentation can be in-source or performed during sample preparation. The 
combination of both can often lead to higher confidence in chemical composition determination. 
There are several methods used to detect molecular fragments.  Native or digested protein 
samples are typically ionized by electrospray ionization (ESI) or matrix-assisted laser desorption 
ionization (MALDI).  Time-of-flight (TOF) mass detection is achieved by applying a given 
potential energy from an electric field source to ionized samples.  The ions acquire a kinetic 
energy that causes the ions to drift in a field-free tube with distance D to a detector, 
 
zeEs =
1
2
mv 2  (1)  
 
where ze is the charge of multiple electrons, E is the electric field, s is the length of the source 
region, m is the mass, and v is the velocity of ions.  The m/z is calculated by measuring the time t 
it takes ions to reach the detector 
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with heavier ions reaching the detector later than lighter ions (van Holde et al., 2006).  
Quadrupole mass analyzers are used to filter ions based on their m/z by selectively 
allowing ions to pass through an electric field produced by four parallel electrodes.  A static 
positive potential is applied to two opposing electrodes, while a static negative potential is 
applied along the other opposing electrodes to concentrate ions towards the central axis of the 
quadrupole.   In addition, an alternating potential is superimposed onto each of these static 
potentials that will defocus ions based on their inertia (mass), therefore causing these ions to 
collide with the electrodes and restrict the ions from reaching the detector.  Each pair of 
electrodes will either selectively remove small or large ions based on their respective charges and 
the potential of the electrodes; electrodes with positive potential will act as a low mass filter to a 
stream of positive ions, while the electrodes with negative potential will act as a high mass filter.  
The frequency of alternating current can be scanned to generate a mass spectrum of a mixture of 
ions to detect a range of m/z values (van Holde et al., 2006).    
Additionally, the m/z of ions can be determined by the cyclotron frequency of the ions in 
a fixed magnetic field.  This method is known as Fourier transform ion cyclotron resonance mass 
spectrometers (FT-ICR-MS) and often further abbreviated as (FTMS).  A moving ion with 
charge q and with velocity v in a uniform magnetic field B will exhibit a force known as the 
Lorentz force.   
BvqamF
 ×==  (3)  
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The magnetic field will cause the ion to move in a circular motion with angular frequency ωc
 
 (in 
rad/s) known as the ion cyclotron frequency.  Ions are then excited by applying an electric field 
oscillating at or near the cyclotron frequency of ions of a particular m/z value.   
Unlike most MS techniques, FTMS does not directly detect m/z, but rather measures the 
frequency of ion rotation and the m/z is extrapolated by applying a Fourier transform to the 
current signal produced by the rotating ions.  Since frequency can be measured much more 
accurately than other parameters, m/z measurements by FTMS have higher resolution and mass 
accuracy than any other type of mass measurement (Marshall et al., 1998).  Because of its high 
resolution and mass accuracy, FTMS has seen a large interest in metabolic profiling and 
identification (Ohta et al., 2010), hydrogen/deuterium (H/D) exchange (Sperry et al., 2008), top-
down proteomics (Ryan et al., 2010) and a number of other MS applications.  
More recently, the Orbitrap mass analyzer was introduced to the proteomics field offering 
similar high resolution and mass accuracy as FTMS but with smaller and less expensive 
instrumentation (Makarov, 2000; Hardman and Makarov, 2003).  The trap consists of a barrel-
like geometry with an axial central electrode that creates a unique electric field.  This field traps 
ions and causes them to both rotate around and oscillate along the axial electrode with a 
harmonic oscillation.  Mass-to-charge values are deduced from the current image obtained from 
the frequency of harmonic oscillations along the axial electrode by applying a Fourier 
transformation exactly as performed with FTMS (Hu et al., 2005).  
 
ω c =
qB
m
 (4)  
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1.3.3 Electron Microscopy 
Conventional biophysical methods such as nuclear magnetic resonance (NMR) and X-ray 
crystallography can be instrumental in elucidating the structure and dynamics of proteins to help 
better understand the function of the given protein.  Investigation of large proteins or protein 
complexes is often hindered, however, due to the size limitations of these techniques.  With the 
advancement of electron microscopy (EM) instrumentation, data collection and processing in the 
past several decades, EM can be a powerful tool that bridges the size gap of several orders of 
magnitude between X-ray crystallography and light microscopy.  The greater resolution obtained 
by EM than light microscopy is owed to the significantly small de Broglie wavelengths of the 
fast electrons used compared to the wavelength of light (Wischnitzer, 1970).  EM is particularly 
useful in structural biology because it allows visualization of large macromolecule structures 
without the need to crystallize samples and with minimal quantity.  
Analogous to basic light microscopy (LM), EM is composed of an illuminating system, 
an optical system, and a recording system to directly view the object.  The illuminating system 
relies on a beam of electrons produced by thermionic or field electron emission, which is then 
magnified and focused by magnetic lenses to a single focal point.  This highly focused electron 
beam then transmits through and interacts with an ultra thin sample, scattering some electrons in 
the process.  An image is produced by the diffraction of electrons with the sample viewed on a 
fluorescent screen, charge-coupled detector (CCD), or film (Wischnitzer, 1970, Frank, 1996).  
Because scattering of the electron beam is dependent on sample density, heavy metal salt 
solutions such as uranyl acetate are used as staining solutions to increase the differential 
scattering of the electron beam, thereby improving image contrast (Watson, 1958).   
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Similar to X-ray crystallography, which averages the diffraction pattern of many particles 
organized in the unit cell of a crystal by translational repetition, EM analysis requires averaging 
thousands of individual images to generate structures with high resolution.  The many images are 
aligned to produce a 2D average of the projected object (Frank, 1996).  EM also captures several 
different conformation classifications during this process and by using the Euler angle of each 
2D average of the sample, a three-dimensional reconstruction is generated of the object 
(Crowther et al., 1970; Mio et al., 2010) 
Although negative staining is advantageous for protecting the sample from radiation 
damage and increasing image contrast, negative staining techniques can also cause distortion to 
the original structure through sample dehydration and denaturation (Bremer, 1992).  By rapidly 
freezing samples in a vitreous state (cryoEM), samples may be preserved in a more natural state 
but with lower image contrast (Stahlberg and Walz, 2008).  The combination of negative stain 
and cryo- EM has afforded investigators the opportunity to reach near atomic resolution of large 
macromolecules and are capable of distinguishing secondary structures such as alpha helices 
(Conway et al., 1997; Zhang et al., 2008; Cheng and Walz, 2009).  
1.3.4 Optical Biosensors  
(Taken verbatim from Daghestani, H.N.; Day, B.W. Theory and applications of surface plasmon 
resonance, resonant mirror, resonant waveguide grating, and dual polarization interferometry 
biosensors. Sensors, 2010, 10, 9630-9646) 
 
Biosensors are useful tools for research in areas of biophysics and pharmaceutical sciences.  The 
obvious advantage biosensors offer over many other biophysical techniques is that it is label-
free, eliminating the need for fluorescent, chemical, or radiolabeled tags.  In addition, biosensor 
technologies are relatively easy to use and offer real-time data collection so that different 
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biochemical interactions can be monitored.  Biosensors have several applications for illuminating 
explanations to questions arising from the study of macromolecular interactions (Lillis et al., 
2006) and the binding of small molecules to surfaces with immobilized biological molecules 
(Cooper, 2002; Karlsson, 2004; Boozer et al., 2006).  The types of biosensor arrangements vary 
greatly and have been previously reviewed.  Examples of biosensor types include 
electrochemical (Wang, 2008; Ronkainen et al., 2010), carbon nanotube field effect (Allen et al., 
2007; Liu et al., 2009), and optical (Fan et al., 2008). Within each of these individual types, there 
are many variations in the instrument designs.  
1.3.4.1 Surface Plasmon Resonance  
Surface plasmon resonance (SPR) was first demonstrated by Otto in 1968 (Otto, 1968), but was 
not made commercially available for biomolecular interaction applications until the fall of 1990 
by BiaCore (GE Healthcare) (Owens, 1997).  As a starting point, we will consider surface 
plasmon polaritons (SPP), which are electromagnetic modes or oscillations arising from the 
interaction of light with mobile surface charges in a metal (typically gold or silver) (Otto, 1968).  
SPPs are transverse magnetic (TM) waves that propagate along the interface between materials 
with negative and positive permittivities (e.g., a metal/dielectric layer).  According to the Drude 
model, the dispersion relation (β) of an SPP, which basically correlates the relationship between 
the wavevector along the interface and the angular frequency ω, can be described by Eq. 5: 
 (5)  
where c is the speed of light in a vacuum, while em and ed are the permittivity of a metal and a 
dielectric material, respectively.  The real part of Eq. 5 determines the SPP wavelength, while the 
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imaginary part determines the propagation length of the SPP along the interface, which is 
responsible for the evanescent field.  Although the electromagnetic field of an SPP decays 
evanescently into both the metal and dielectric medium, the majority of the field is present in the 
dielectric medium due to increased damping in the metal (Figure 11) (Novotny and Hecht, 2006).  
As a result, the real part of the dispersion function is very sensitive and changes proportionally to 
changes in the refractive index (Homola, 2003).  The principle of SPR, however, only occurs 
when the light’s wavevector component parallel to the metal surface matches that of the SPP.  
This condition is only satisfied at distinct angles of incidence, appearing as a drop in the 
reflectivity of incident light (Novotny and Hecht, 2006).  SPR biosensing relies on the principle 
that any changes on the dielectric sensing surface will correspond to a shift in the angle of 
reflectivity, followed by a detector, in order to satisfy the resonance condition (Figure 12).
 
After Otto demonstrated the ability to excite SPPs with his proposed configuration, a 
number of other configurations followed suit including prism coupling (Kretschmann 
configuration; also referred to as attenuated total reflection (ATR)) (Kretschmann, 1971), 
waveguide coupling (Harris and Wilkinson, 1995), grating coupling (Yu et al., 2004), and fiber 
optic coupling (Marazuela and Moreno-Bondi, 2002).  In the case of the Kretschmann 
configuration, incident light passes through a prism with a high index of refraction causing the 
light to internally reflect at the metal/prism boundary.  The total internal reflection creates an 
evanescent wave that penetrates the thin metal layer and propagates along the metal/prism 
interface. The angle of incident light is varied in order to match the evanescent wave propagation 
rate with the propagation rate of the SPP (Kretschmann, 1971).  Grating coupling may also be 
used to excite SPPs by stimulating a periodic metal diffraction layer with incident light so that 
the propagation constant also matches that of the metal/dielectric surface (Homola, 2003; Yu et 
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al., 2004).  Waveguide coupling relies on exciting SPPs when the guided light and the SPPs are 
phase matched (Homola et al., 1997).  
 
Figure 11. Schematic of a Surface Plasmon Resonance Biosensor 
 Kretchmann configuration of an SPR biosensor.  Light reflected from a prism induces an evanescent field 
in both the metal and dielectric (biological) layer, with the field being greater in the latter.  Light is then reflected out 
of the prism and a detector records the angle at which resonance is satisfied. 
 
Regardless of the configuration, environmental changes in the dielectric medium cause an 
alteration to the phase, amplitude, polarization or spectral distribution of the incident light, which 
can be attributed to changes in the propagation constant and, hence, changes in the refractive 
index are detected in real time.  Piliarik and Homola (2009) recently presented a theoretical 
analysis evaluating the sensitivity of SPR detection, suggesting that many of the current systems, 
regardless of their instrumental arrangement, very nearly approach their theoretical limits.  
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Figure 12. Detection of Binding Events with an SPR Biosensor 
As analyte begins to flow over the sensing layer and binds to substrate, the angle of reflectivity that 
satisfies the resonance condition will change accordingly until it reaches saturation and all the binding sites have 
been occupied. The dissociation of analyte from the substrate causes the angle of the detector to return back to 
baseline once all the analyte has been completely removed. 
 
The most common use for SPR sensing is to evaluate protein-ligand (Jung et al., 2000), 
protein-protein (Karlsson and Falt, 1997), or nucleotide hybridization (Moon et al., 2010) events.  
Since it is typically not advantageous to directly deposit biological molecules onto surfaces, 
especially surfaces of inert metals such as silver or gold, surface functionalization can create a 
more functionally active environment and reduce non-specific binding on the surface.  
Advancements in surface chemistry have allowed researchers to easily customize a sensing 
surface to their particular needs.  One of the most commonly used surfaces includes those 
prepared through amine chemistry, such as N-hydroxysuccinimide (NHS)-derivatized surfaces 
(Johnsson et al., 1991; Macbeath and Schreiber, 2000; Rusmini et al., 2007) that nonspecifically 
bind to the nucleophilic amino groups of peptides and proteins.  Similarly, maleimide and other 
thiol-reactive groups (Lee at al., 2005; Rusmini et al., 2007) are useful for binding proteins 
containing surface reactive cysteines.  Pegylation (polyethyleneglycol) (Lu et al., 2000; Rusmini 
et al., 2007) is another functionalization method that is often used in biosensor applications.  
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Additionally, surfaces have also been mimicked to resemble lipid bilayers for studies involving 
membrane proteins (Fang et al., 2002; Taylor et al., 2009).  Protein-carbohydrate interactions 
can also be monitored by glycan-modified surfaces (Feizi et al., 2003; Wang, 2003).  By taking 
advantage of the extremely strong affinity of biotin for avidin or streptavidin, biotinylated 
surfaces (Nidumolu et al., 2006) can be particularly useful for capturing labeled proteins, as we 
have recently demonstrated (Daghestani et al., 2009).  Nickel nitrilotriacetic acid (Ni-NTA)-
derivatized surfaces (Zhu et al., 2001; Wegner et al., 2003) are also convenient for specific 
capturing of proteins that have been genetically engineered with an N- or C-terminal 
polyhistidine tag, a common affinity moiety used during protein expression and purification 
processes.  
High contrast SPR microscopy or imaging was first described by Rothenhausler and 
Knoll (1988) and was seen as a method to increase the throughput of standard SPR biosensors 
(Jordan et al., 1997; Bassil et al., 2003; Shumaker-Parry et al., 2004), but suffered from reduced 
sensitivity compared to conventional SPR.  Advances in microfabrication and micromachining 
techniques have assisted in the development of lab-on-chip sensors with better sensitivity and 
greater numbers of sample chambers within a single chip.  These advancements have played a 
role in SPR imaging developments for high throughput biosensor screening.  Piliarik et al. 
(2005) developed a more sensitive SPR imaging sensor that combines polarization contrast and 
special SPR multilayer structures capable of screening 108 samples simultaneously at a 
concentration as low as 500 ng/mL and with minimal crosstalk between chambers.  A chip 
proposed by Ouellet et al. (2010) demonstrated the ability to simultaneously monitor multiple 
ligands against different analytes and at different concentrations by using a parallel 264-
microarray chamber with the aid of a high resolution CCD camera.  In addition to the increased 
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number of events detected, the microfluidics was designed for small reaction volumes (as low as 
700 pL), reducing unnecessary sample consumption.  The authors also demonstrated the ability 
to recover samples after SPR measurements with minimal cross-contamination.  
In recent years, the information obtained from SPR has also been used to complement the 
information obtained from MS, providing both quantitative and qualitative information (Krone et 
al., 1997).  The combined use of SPR and MS can be used for functional proteomic screening, 
identifying protein-protein interactions and further characterizing domains involved in the 
interactions (Buijs and Franklin, 2005; Ohman et al., 2008).  This technique can also be used for 
screening of a number of toxins for their ability to bind a particular ligand, followed by MS 
analysis to determine the chemical composition of the small molecules (Nedelkov et al., 2000; 
Nedelkov and Nelson, 2003).  Another application involves searching for and characterizing 
enzyme inhibitors (Borch and Roepstorff, 2004).  Some investigators have attempted to elute 
samples off of and collect samples directly from the sensor and then analyze the eluates by 
MALDI-TOF-MS (Nelson et al, 1997; Sonksen et al., 1998).  Without taking strenuous care, 
such sample transfer techniques can lead to a great amount of sample loss between steps and can 
be very time consuming unless more efficient techniques, such as the chip proposed by Ouellet et 
al. (2010), can be put into such practice.  Other ways to minimize sample losses include applying 
MALDI matrix directly onto the sample sensor, which is then physically secured onto a MALDI 
target to analyze samples directly without an elution step.  This technique, however, is 
destructive to the sample chip and introduces sources of error since not all chips are identical in 
terms of thickness (∆thickness = ∆distance from the MALDI-TOF-MS ion detector, and 
therefore ∆TOF).  Natsume et al. (2000) showed it possible to collect the samples used in a 
BiaCore SPR instrument by trapping the sample into a reverse-phase (RP) capillary column 
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placed in tandem after the sample sensor.  In Natsume et al.’s configuration, once the desired 
measurements were obtained from the SPR, the sample flow was started so that buffer eluted the 
sample from the sensor chamber into the RP capillary column.  After the sample was collected 
on the RP capillary column, the column was transferred to a liquid chromatography system to 
separate sample constituents followed by ESI-MS analysis (Natsume et al., 2000).  It is not 
feasible to flow samples from an SPR sensor directly to a MS because salts and stabilizers that 
are present in buffers can often wreak havoc on an ESI-MS system by damaging the ESI needle 
and decrease the quality of the MS spectra (by, e.g., diluting signals across several adduct 
species, ion suppression, and increasing the noise-to-signal ratio) (Annesley, 2003).  An 
alternative method is to use an ultra-rapid desalting technique consisting of a microchannel 
laminar flow device connected online with an ESI-MS (Wilson and Konermann et al, 2005).  
From these examples, it is evident that combining biosensors with MS offers a promising future 
at providing immediate structural and behavioral information about potential biologically 
important agents (therapeutics, toxins, etc.) in a relatively short period with minimal sample loss.  
1.3.4.2 Resonant Mirror Biosensor 
The resonant mirror (RM) setup is a leaky waveguide structure that first became commercially 
available as IAsys in 1993 by Fisons Applied Sensor Technologies (Owen, 1997).  Although the 
commercial availability of this instrument was recently discontinued, it is still important to note 
its application and contribution to the field.  The RM configuration is similar to SPR’s 
Kretschmann configuration, but differs in that RM relies on coupling of incident light through a 
prism with a high-index dielectric layer, rather than a metal surface (Figure 13).  This 
replacement combines the simple structure of SPR systems with the enhanced sensitivity of 
waveguide structures to produce sharper resonance peaks than SPR (Lukosz, 1991), thereby 
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increasing the sensitivity of the technique.  As light passes through the prism to a low-index 
medium, it couples with the high-index resonant layer, thereby allowing total internal reflection 
to occur at the boundary of the sensing layer.  Similar to SPR, resonance only occurs when the 
angle of the incident light and the resonant modes in the high-index layer are phase-matched, 
resulting in strong reflection at the output.  Any change in the refractive index of the biological 
layer at the surface corresponds to a change in the angle of light that satisfies this resonance 
condition (Nellen and Lukosz, 1991; Cush et al., 1993).  Although the waveguide structure of the 
RM allows for both TM and transverse electric (TE) resonances (with different angles) to occur, 
generally only one is physically measured since TM and TE modes diverge when adjusting the 
thickness of the resonant structure for optimal sensitivity (Cush et al., 1993). 
Identical to SPR, RM has been used to monitor many different molecular interactions of 
macromolecules (Buckle et al., 1993; Duchesne et al., 2006; Benadie et al., 2008; Lemmer et al., 
2009) and has parallel capabilities in terms of surface modifications.  The cuvette structure of the 
RM biosensor, however, provides an advantage over flow through microfluidic systems 
commonly used in SPR when sample conservation is imperative.  Use of a stirring bar in the 
cuvette is also helpful since the constant mixing limits mass transport effects (Owen, 1997).  
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Figure 13. Schematic of a Resonant Mirror Biosensor 
Light reflected from a prism is coupled to a resonant structure (low and high index coupling layers) to 
produce an evanescent wave at the sensing surface. Light is then reflected out of the prism and a detector records the 
angle at which resonance is satisfied. 
1.3.4.3 Resonant Waveguide Grating Biosensor 
Although diffraction grating was a phenomenon described over a century ago (Wood, 1902), its 
application in sensing was not employed until the early 1980’s when Tiefenthaler and Lukosz 
applied grating couplers for gas (1985) and chemical (1989) sensing.  In 2002, Cunningham et 
al. (2002) demonstrated the use of a resonant diffractive grating surface to monitor biochemical 
binding events, which was commercialized as BIND® by SRU Biosystems.  The resonant 
waveguide grating (RWG) biosensor is also based on a leaky mode waveguide structure.  A 
subwavelength structured surface is introduced by sandwiching a two-dimensional grating 
between a substrate and a cover layer that fills the gaps between the gratings, which in turn 
creates a waveguide when the effective index of refraction of the grating is greater than the 
substrate or the cover (Cunningham et al., 2002).  Incident light, from either side of the grating 
(Teifenthaler and Lukosz, 1989), propagates through and couples into the waveguide by means 
of the grating, resulting in a narrowband of reflected or transmitted wavelengths detected as the 
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output (Figure 14) (Cunningham et al., 2004).  Similar to SPR and RM, any change in the 
biological or sensing layer will cause a change in the reflected or transmitted wavelength 
(Cunningham et al., 2000; Fang, 2007).  Corning Inc., has also introduced its Epic®
 
 version of 
the RWG biosensor and both companies have made modifications to their original designs to 
increase sensitivity and by offering 96-, 384-, and 1536-well plates suitable for high throughput 
screening (Cunningham et al., 2004; Fang, 2010a). Others have performed theoretical analyses 
on RWG structures to optimize the design and fabrication of grating structures in an attempt to 
improve sensitivity (Yih et al., 2006).  RWG biosensors are capable of monitoring the binding of 
small molecules to proteins (Cunningham et al., 2002; Lin et al., 2002; Li et al., 2004) as with 
SPR and RM, but have most notably been used to monitor mass redistribution of proteins and 
organelles of live cells upon treatment with test agents (Fang et al., 2006; Fang, 2007; Xi et al., 
2008; Fang et al., 2008; Fang et al., 2010b).  Changes in cell adhesion and extracellular matrix 
components play an important role in cell development and migration and it is evident that 
certain changes in cell adhesion also contribute to a number of diseases (Parsons et al., 2010).  
The ability of RWG biosensors to monitor changes of cell adhesion of live cells in real time 
make it an attractive tool in drug discovery.  A drawback of evaluating cells with biosensors 
arises due to the large size of cells (several microns) and the limited penetration depth of an 
evanescent wave (~100 nm), results can be misleading since observations are only made to a 
limited portion of the cell (Fang et al., 2006).  
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Figure 14. Schematic of a Resonant Grating Waveguide Biosensor 
Broadband light is incident from either the substrate or cover layer side of the structure, which then 
diffracts and couples into the grating waveguide structure.  A detector records the wavelength of the narrowband 
light reflected at which resonance is satisfied.  
1.3.4.4 Dual Polarization Interferometry Biosensor 
Dual polarization interferometry (DPI) is another evanescent technique that has seen a large 
increase in interest by the scientific community over the past decade since the technique was first 
commercialized in 2000 by Farfield Group, Ltd.  DPI utilizes a waveguide structure that consists 
of a stack of dielectric layers with reference and sensing layers separated by a layer of cladding 
that mimics Young’s 2-slit experiment in optics (Cross et al., 2004).  A top dielectric layer is 
etched to reveal the sensing layer so that two separate channels can be present on a single sensor 
chip (Figure 15).  Light from a laser is passed through the sandwiched waveguide structure and 
an interference pattern is detected on the opposing side by a CCD camera.  Any changes in 
refractive index that take place on the sensing layer alter the phase position of the fringes relative 
to the reference layer and are detected in real time, 
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∆φ = k ′ L ∆ns (5)  
where ∆φ is the change in the phase position of a fringe, k is the propagation constant, L′ is the 
pathlength and is constant, and ∆ns
 
 is the effective change in the refractive index of the sensing 
waveguide (Cross et al., 2004).   
 
Figure 15. Schematic of a Dual Polarization Interferometer Biosensor 
Schematic of a DPI sensor chip and the interference pattern produced when light is applied onto the side of 
a chip.  The phase shift of the fringes (TM and TE) are recorded in real time and data is resolved, where only one 
value of thickness and absolute refractive index at any given time-point t will satisfy Maxwell’s equations of 
electromagnetism for both TM and TE polarizations. 
 
Unlike SPR, which utilizes only the TM mode, DPI takes advantage of measuring both the 
TM and TE polarizations (Swann et al., 2003; Swann et al., 2004; Cross et al., 2004).  
Maxwell’s equations of electromagnetism for a system of uniform multiple dielectric layers are 
employed to provide the absolute effective index for both the TM and TE waveguide modes 
determined from the refractive index and thickness of each layer from each polarization (Cross et 
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al., 2004).  This ultimately gives the relationship between changes in the effective index of 
refraction ∆neff of the waveguide in each mode and changes of thickness of the adsorbed layer tad
 
∆neff =
∂neff
∂tad
 
 
 
 
 
 ∆tad +
∂neff
∂nc
 
 
 
 
 
 ∆nc
 
(in nm) 
 (6)  
where ∆nc is the change in refractive index of the medium covering the waveguide (i.e., buffer) 
(Teifenthaler and Lukosz, 1989; Brandenburg et al., 2000).  Changes to the adsorbed layer will 
result in a change to the effective index of each mode that can satisfy a continuous distribution of 
thickness and refractive index values with only one unique solution that satisfies both the TM 
and TE modes.  In addition, the molar surface coverage Γ (in nm2⋅molecule-1
 
Γ =
nad − nc
dnad dC
tad
) can be related to 
the thickness of the adsorbed layer 
 (7)  
where nad is the refractive index of the adsorbed layer and C is the concentration.  Consequently, 
the density ρ (in g⋅cm-3
 
Γ =
ρ
M
tad
) of sample on the surface can be calculated for biological samples with 
known molecular weight M (Cross et al., 2004) since molar surface coverage can also be written 
as 
 (8)  
The use of both polarizations to determine effective refractive index and thickness values 
is clearly a great advantage over SPR, RM, RWG, and other optical biosensor techniques that 
only report relative changes of refractive index obtained from only one polarization.  Swann et 
al. (2003) proposed an elegant matrix that assists interpreting DPI data by correlating the 
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different parameters (thickness, density, mass coverage) calculated from both the TM and TE 
responses.  This type of detailed information can be extremely helpful for characterizing the 
conformational changes of macromolecular interactions (Swann et al., 2003; Thompsett and 
Brown, 2007; Sonesson et al., 2008) and the design of surfaces for optical biosensors 
(Daghestani et al., 2009; Popplewell et al., 2009).  
Before any of the above calculations are performed, each individual chip must be 
calibrated.  Sample injections of degassed 4:1 (w/w) water-ethanol followed by deionized water 
are typically used to calibrate individual chips because of their known index of refractions (Cross 
et al., 2004).  One disadvantage of DPI is that an experiment must be performed continuously in 
order to follow the phase shift of the projected interference pattern so that thickness and 
refractive index values can be computed.  This can hinder calibration results if a chip requires ex 
situ modification throughout an experiment.  A solution to this issue, however, was recently 
proposed by modifying the channel so that multiple pathlengths are measured (Coffey et al., 
2009).  With this adjustment, the number of 2π cycles of the phase shift can be determined if the 
chip is removed from the instrument, thereby allowing ex situ modification of the chip without 
the loss of any information.  
In addition to the same applications of SPR and RM (Berney and Oliver, 2005; Ricard-
Blum et al., 2006), DPI has proven to be a powerful technique for characterizing structural 
dimensions of proteins (Lin et al., 2006) and has recently been shown to be an instrumental tool 
for characterization of membrane/liposome structure and mimetics (Terry et al., 2006; 
Popplewell et al., 2007; Mashaghi et al., 2008; Lee et al., 2010).  Another unique application to 
DPI that recently emerged is the ability to monitor early stages of protein crystallization 
processes by measuring light loss from the waveguide caused by changes in lateral surface 
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structure (Boudjemline et al., 2008).  Not only does this provide insights into the mechanism of 
protein crystallization, but also has the potential to assist crystallographers in the optimization of 
conditions and times required for successful protein crystallization.  More recently, information 
from phase measurements has been supplemented by optical extinction measurements due to 
light absorption to provide additional information of DNA-small molecule interactions (Wang et 
al., 2010).  
It should be noted that any of the above mentioned biosensors can be used to determine 
the kinetics of biomolecular interactions from the rates of association kass and dissociation kdiss
  
 
d[SL]
dt
= kass[S][L] − kdiss[SL] 
 of 
a substrate-ligand complex by monitoring the change in response of binding as a function of time 
and concentration 
 (9)  
where [S] and [L] are the concentrations of free substrate and ligand, respectively, while [SL] is 
the concentration of the formed complex (Dmitriev et al., 2003).  At equilibrium, the association 
of ligand to the surface can be followed by the pseudo first order equation 
 
Rt =
Rmaxkass[L]
kass[L]+ kdiss
1− e−(kass [L ]+kdiss )t( ) (10)  
where Rt is the response of the detector at a given time and Rmax is the maximal response signal 
upon saturation (Edwards et al., 1998).  Typically, experiments are performed by varying the 
amount of ligand added to the substrate, producing curves with different observed rate constants 
kon.  By plotting the kon against the varying concentration of ligand, Eq. 11, a straight line is 
typically produced with a slope of kass and y-axis intercept of kdiss
  
 
kon = kass[L]+ kdiss  
 (George et al., 1995).  
 (11)  
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This information can then lead to the association Ka and dissociation Kd
  
 
Ka =
1
Kd
=
kass
kdiss
 
 equilibrium 
constants because of the below relationship (Dmitriev et al., 2003) 
 (12)  
With a similar type of analysis as described above, kinetic values from second order reactions 
may also be calculated as previously described (George et al., 1995; Edwards et al., 1998). 
Biosensors offer label free detection of biomolecular interactions with applications in 
environmental safety, bioterrorism, biomedical research and drug discovery.  Several designs are 
capable of detecting biomolecular interactions.  Surface plasmon resonance, resonant mirror, 
resonant waveguide grating, and dual polarization interferometry biosensors are commonly used 
techniques with commercial availability.  SPR, being the most widely used technique in the field, 
has provided researchers with a wealth of information ranging from evaluation of many different 
biomolecular interactions to advances in sensor design.  Progress in chip design has allowed for 
smaller sample volumes, not only to save valuable samples, but also to increase rates of the 
reactions by reducing diffusion distances.  Advances in computer automation and the software to 
analyze the exquisite data that arise from the discussed methods has also played an important 
role in greater reproducibility and easier sample handling with all three of the biosensor types 
capable of employing autosamplers.  Although SPR is one of the most commonly used biosensor 
techniques, the cuvette structure of RM offers an advantage over both SPR and DPI because of 
its ease of use and ability to reduce sample consumption compared to microfluidic devices.  
Since the IAsys system has recently been discontinued, RWG structures offered by SRU 
Biosystems and Corning, Inc. offer an alternative method that takes advantage of the increased 
sensitivity of a waveguide structure in addition to the high throughput applicability from the 
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multi-well plates available.  On the other hand, DPI offers a unique avenue of monitoring 
biomolecular interactions and the detailed structural changes that take place during these 
interactions.  Overall, biosensors are immensely useful in many different applications and future 
research aims at improving the sensitivity and throughput of these devices for greater 
reproducibility and applicability to larger sets of data acquisition.   
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2.0  MATERIALS & METHODS 
2.1 MATERIALS 
ATP, GTP, gentamicin, MES, MSG, and PIPES were from USB, Affymetrix, Inc., USA.  
Formaldehyde and DTT were from Fisher Scientific, Inc.  The 1280-LOPAC Library, CaCl2, 
CNBr, dextran blue, DMSO, EGTA, glutathione, glycerol, HEPES, Hoechst 33342, imidazole, 
iodoacetamide, KCl, 2-mercaptoethanol, MgCl2, NaN3, NEM, PBS, Protease Inhibitor Cocktail, 
TCEP, TRIS-HCl, and tyrosinase were from Sigma-Aldrich.  EDTA was from Boehringer 
Mannheim, Germany.  Coomassie blue stain was from BioRad.  Thioglo1 (Covalent Associates, 
Inc.) was generously provided by Dr. Valerian Kagan. Alexa-595, DMEM medium, G418, L-
glutamine, High Five Cells, Express Five® Serum Free Medium (SFM), Grace’s Insect 
Medium, fetal bovine serum (FBS), Fungizone, nonessential amino acids, Pen-Strep, 
NuPAGE® Novex 4-12% Bis-Tris Gels, NuPAGE® Novex 3-8% Tris-Acetate Gels and their 
respective running buffers, Green Polar Screen Glucocorticoid Receptor Competitor Assay 
Kit, sodium pyruvate, and HiMark Pre-stained Protein Standard were from Invitrogen, Inc. 
Full-Range Rainbow Molecular Weight Marker was from GE, Healthcare Life Sciences.  
BCA Protein Assay Kit, EZ-Link NHS-LC-Biotin, and bovine serum albumin (BSA) Standard 
were from Pierce.  PiColorLock Gold was from Innova Biosciences, UK.  Kinesin heavy chain 
motor domain from H. sapiens and myosin II from rabbit skeletal muscle were from 
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Cytoskeleton, Inc.  Trypsin Gold, Mass Spectrometry Grade was from Promega Corp.  HPLC 
grade water was from Mallinkckrodt Baker, while HPLC grade CH3
2.2 METHODS 
CN was from Honeywell 
Burdick & Jackson.  Drs. Michael Cascio and Tedd Ross generously provided Sf9 cells.  Dr. 
Jeffery Brodsky generously provided Hsc82 and Ssa1p protein along with 17-AAG. The 3617.4 
mouse mammary adenocarcinoma cell line stably expressing GR-GFP under the control of a 
tetracycline regulated promoter was kindly provided by Dr. Gordon Hager from the Laboratory 
of Receptor Biology and Gene Expression, NCI, Bethesda, MD. Triton X-100 and Tween20 
were from BioRad.  Mouse monoclonal anti-α-tubulin antibody was obtained from 
NeoMarkers/Lab Vision Inc., Freemont, CA.  Cy3 donkey anti-mouse was obtained from 
Jackson ImmunoResearch Laboratories, Inc., West Grove, PA.  Paclitaxel was obtained from the 
NIH Drug Synthesis Branch.  Dynein translocation test agents used were obtained from the 
NIH’s Molecular Libraries Screening Centers Network (MLSCN).   
2.2.1 Protein Purification 
2.2.1.1 Tubulin Isolation and Purification from Bovine Brain 
Tubulin was isolated from three freshly obtained bovine brains according to a modified 
procedure of that reported by Hamel and Lin (1984).  Bovine brains were homogenized in a 
blender containing 0.75 mL/g of 0.1 M MES, pH 6.4, containing 1 mM EGTA, 4 M glycerol, 1 
mM MgCl2, 1 mM 2-mercaptoethanol, 0.1 mM EDTA, and 0.1 mM GTP (Solution A). The 
homogenate was clarified by centrifuging at 6,000 rpm for 15 min at 0 °C and the supernatant 
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was centrifuged at 28,000 rpm (90,000g) for 44 min at 0 °C using a Ti-45 Beckman-Coulter 
rotor.  ATP and GTP were added to the supernatant to give final concentrations of 1mM and 0.3 
mM, respectively and the solution was incubated for 40 min at 37 °C. The solution was 
centrifuged at 28,000 rpm (90,000g) for 44 min at 37 °C.  The supernatant was discarded and the 
pellet was resuspended in 10 mL/brain of the above-described MES buffer without glycerol 
(Solution B) and incubated on ice for 30 min.  For each 1 mL of solution, 0.553 g of glycerol 
was added to give a final concentration of 4 M. ATP and GTP were then added to give final 
concentrations of 1 mM and 0.3 mM, respectively and the mixture was incubated for 1 h at 37 
°C.  The solution was centrifuged at 28,000 rpm (90,000g) for 44 min at 37 °C and the pellet was 
resuspended in 6.25 mL/brain of Solution B.  The resuspended pellet was incubated on ice for 30 
min and centrifuged at 24,000 rpm (67,000g) for 30 min at 0 °C.  Lyophilized MES (2M, pH 6.9) 
was added to the solution to give a final concentration of 1.6 M followed by the addition of 1 
mM GTP and 2 mM DTT and the mixture was incubated for 45 min at 37 °C. The mixture was 
centrifuged at 28,000 rpm (90,000g) for 44 min at 37 °C and the pellet was resuspended in 10 
mL cold 1 M MSG, pH 6.6.  The mixture was incubated on ice for 2 h and then centrifuged at 
28,000 rpm (90,000g) for 30 min at 0 °C.  To the supernatant, 1 mM GTP was added and the 
solution was incubated for 1 h at 37 °C and the mixture was then centrifuged at 28,000 rpm 
(90,000g) for 90 min at 37 °C.  The pellet was resuspended in 10 mL of cold 1 M MSG, pH 6.6 
and incubated on ice for 1 h.  The solution was centrifuged at 28,000 rpm (90,000g) for 1 h at 0 
°C and the supernatant contained soluble tubulin.  The electrophoretic homogeneity of the 
protein was determined with a 4-12% Bis-Tris SDS-PAGE gel electrophoresis run at 150 V for 1 
hr and stained with Coomassie Blue Stain.  The concentration was determined by a BCA Protein 
Assay kit using BSA as a standard. 
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2.2.1.2 Cytoplasmic Dynein Isolation and Purification from Bovine Brain 
Cytoplasmic dynein was isolated from two freshly obtained bovine brains.  Bovine brains were 
homogenized in a blender with 0.75 mL/g of an extraction buffer containing of 50 mM HEPES, 
50 mM PIPES, pH 7.2, containing 2 mM MgCl2 and 1 mM EDTA with a protease inhibitor 
cocktail tablet.  The homogenate was clarified by centrifuging at 6,000 rpm for 30 min at 4 °C 
and the supernatant was centrifuged at 28,000 rpm (90,000g) for 1 h at 4 °C using a Ti-45 
Beckman-Coulter rotor.  PTX and was added to the supernatant to give a final concentration of 
20 µM and the solution was incubated for 20 min at 37 °C.  During this time, a prewarmed 6 mL 
solution of the extraction buffer with 7% sucrose was added to each of the ultracentrifugation 
tubes.  The supernatant solution was slowly added to the tubes, which were then centrifuged in a 
Ti-45 rotor at 20,000 rpm (46,500g) for 30 min at 30 °C.  The supernatant was carefully removed 
and the pellet was resuspended in 15 mL/brain of the extraction buffer containing 5 µM PTX and 
3 mM GTP, then incubated for 15 min at 37 °C.  The solution was then centrifuged in a Ti-45 
rotor at 28,000 rpm (90,000g) for 30 min at 30 °C.  The pellet was then resuspended in 10 
mL/brain of the extraction buffer containing 5 µM PTX and 3 mM GTP.  The mixture was 
incubated for 20 min at 37 °C and then centrifuged in a Ti-45 rotor at 28,000 rpm (90,000g) for 
30 min at 20 °C.  The pellet was resuspended in 10 mL/brain of extraction buffer containing 3 
mM GTP and 10 mM ATP.  The mixture was incubated for 10 min at 37 °C to release 
cytoplasmic dynein from MTs and the supernatant was collected after a final centrifugation in a 
Ti-70.1 rotor at 30,000 rpm (104,600g) for 30 min at 20 °C.  The sample was further purified by 
size exclusion chromatography using a Shodex WS-804F column on a Summit HPLC System 
(Dionex).  The column was pre-equilibrated with 10 mM HEPES, 10 mM PIPES, pH 7.2 with 
0.05% (w/v) NaN3 at a flow rate of 0.75 mL/min at 8 °C.  The elution was monitored by the 
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absorption at 210 and 254 nm and dextran blue (2 MDa), tyrosinase (128 kDa), and BSA (68 
kDa) were used as molecular weight standards.  Multiple elutions were pooled and concentrated 
with an Amicon®
2.2.1.3 Rat Cytoplasmic Dynein Heavy Chain 1 Expression and Purification 
 Ultra-15 (100 kDa NMWL) centrifugal filter device at 5000g for 
approximately 30 min or until a final volume of 50-100 µL is obtained.  The electrophoretic 
homogeneity of the protein from the retentate was determined from a 3-8% Tris-Acetate SDS-
PAGE gel electrophoresis run at 150 V for 1 h and stained using Coomassie blue.  Protein 
concentration was determined by a BCA Protein Assay kit using BSA as a standard. 
The 380 kDa motor domain fragment was expressed as described by Hook et al. (2005). Briefly, 
the gene encoding rat cytoplasmic dynein motor domain (Gly1286-Glu4644) with a C-terminal 
in-frame hexahistidine tag was inserted into the baculovirus expression vector pVL1393 (BD 
biosciences) engineered by the laboratory of Dr. Richard Vallee (Columbia University).  Small 
aliquots of engineered virus were generously provided by Dr. Vallee, which were then amplified 
by infecting Sf9 cells, generously provided by Drs. Michael Cascio and Ted Ross, and collecting 
the media after 3-4 days post infection.  Hi5 cells (Invitrogen) were infected with the virus for 40 
h.  The cells were then washed and resuspended in phosphate buffered saline (PBS), and the 
recombinant motor domain fragments were extracted from the cells by homogenization in the 
presence of a protease inhibitor cocktail.  Extracts were spun at 5,000g for 10 min and then 
100,000g for 30 min. The supernatant was applied to a Ni-NTA Superflow (Qiagen, USA) 
column pre-equilibrated with 50 mM PIPES, 50 mM HEPES, pH 7.2, containing 2 mM MgCl2 
and 2 mM EGTA.  The column was washed with 16 volumes of buffer containing 20 mM 
imidazole before eluting the protein with buffer supplemented with 125 mM imidazole.  The 
imidazole was removed using a PD-10 Desalting Column (GE Healthcare Life Sciences) and 
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sample was resuspended in 10 mM PIPES, 10 mM HEPES, pH 7.2, containing 0.4 mM MgCl2
2.2.2 DEX-induced Glucocorticoid Receptor Translocation HCS Assay  
 
and 0.4 mM EGTA.  The electrophoretic homogeneity of the protein was determined from a 3-
8% Tris-Acetate SDS-PAGE gel electrophoresis performed at 150 V for 1 h.  Protein 
concentration was then determined by a BCA Protein Assay kit with BSA as a standard.   
2.2.2.1 Cell Culture 
The 3617.4 cell line (Walker et al., 1999) was maintained by Sunita Shinde (University of 
Pittsburgh Drug Discovery Institute) in complete culture medium containing 10 µg/mL 
tetracycline (Tet-on) in a humidified incubator at 37°C, 5% CO2 and 95% humidity to keep the 
expression of GR-GFP repressed; DMEM medium with 2 mM L-glutamine supplemented with 
10 % FBS, 100 µM nonessential amino acids, 100 µM sodium pyruvate, 100 U/mL penicillin 
and streptomycin, and containing 0.96 mg/mL G418.  To induce GR-GFP expression in the 
3617.4 cell line, cells were cultured for 48 hrs in the same tissue culture medium without the 
tetracycline (Tet-off). 3617.4 cells that had been cultured in Tet-containing complete culture 
medium were detached from tissue culture flasks by trypsinization, cells were centrifuged at 
500g for 5 min, re-suspended in 10 mL of Tet-free induction medium and viable cells that 
excluded trypan blue were counted in a haemocytometer. 3617.4 cells were adjusted to 4.2 x 104 
cells/mL in Tet-free induction medium and then 60 µL of cell suspension per well were 
dispensed into the wells of 384-well black walled clear bottom plates using the Zoom liquid 
handler (Titertek, Huntsville, AL) to give a final seeding density of 2500 cells/well. Assay plates 
were incubated under Tet-off conditions for 48 hours at 37 °C, 5 % CO2 in a humidified 
incubator and then diluted compounds (20 µL) were added to wells in columns 3 through 22 
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using an Evolution P3 (Perkin-Elmer, Waltham, MA) outfitted with a 384-well transfer head for 
a final screening concentration after DEX addition of 20 µM.  Compound treated plates were 
incubated at 37 °C, 5 % CO2 in a humidified incubator for 60 minutes and then 20 µL of 5.0 µM 
DEX (1.0 µM final in well) was transferred to assay plates using the Evolution P3 liquid handler 
outfitted with a 384-well transfer head. The plate control wells were located in columns 1, 2, 23 
and 24 and the minimum controls (n=24) were treated with 0.5% DMSO and the maximum 
control wells (n=32) were exposed to 1.0 µM DEX and 0.5% DMSO. Assay plates were 
incubated for 30 min at 37 ºC, 5% CO2 and 95% humidity and then the contents of the wells 
were aspirated and replaced with 50 µL of 3.7% formaldehyde containing 2 µg/mL Hoechest 
33342 in PBS without Ca2+ and Mg2+
2.2.2.2 Image Acquisition 
, pre-warmed to 37 ºC, using a BioTek ELx405 (BioTek, 
Winooski, VT) plate washer and cells were fixed for 10-30 min at ambient temperature. The 
fixative was then aspirated and plates were then washed twice with 50 µL PBS using the BioTek 
ELx405 (BioTek, Winooski, VT) plate washer and sealed with adhesive aluminum plate seals 
using the Abgene Seal-IT 100 plate sealer (Abgene, Rochester, NY) with the last 50 µL wash of 
PBS in place.   
Images of two fluorescent channels (Hoechst and FITC) were sequentially acquired on the 
ArrayScan VTI (AS-VTI) automated imaging platform (Thermo Fisher Scientific, Waltham, MA) 
using a 10x 0.3NA objective and the XF100 excitation and emission filter set to obtain images of 
stained nuclei and GR-GFP. Excitation was provided by an X-CITEÒ 120 watt high pressure 
metal halide arc lamp with intelli-lamp™ technology (Photonic Solutions Inc. Mississauga, 
Canada). Typically with the 10x 0.3NA objective, the AS-VTI was set up to acquire 500 selected 
objects (nuclei) or two fields of view, whichever came first.  
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2.2.2.3 Image Analysis 
The nucleic acid dye Hoechst 33342 was used to stain and identify the nucleus, and this 
fluorescent signal was used to focus the instrument and to define a nuclear mask for the 
Molecular Translocation image analysis algorithms. To quantify the DEX-induced translocation 
of GR-GFP from the cytoplasm to the nucleus, images were analyzed using the Molecular 
Translocation image analysis algorithm as described previously (Trask et al., 2009).  Hoechst 
stained objects in Ch1 that exhibited the appropriate fluorescent intensities above background 
and morphological size characteristics (width, length, and area) were identified and classified by 
the image segmentation as nuclei.  The nuclear mask derived from Ch1 was then used to segment 
the GR-GFP images from Ch2 into nuclear (Circ) and cytoplasmic (Ring) regions. The nuclear 
mask was eroded by 1 pixel to reduce cytoplasm contamination within the nuclear area, and the 
reduced mask was used to quantify the amount of target channel GR-GFP fluorescence within 
the nuclear region. The nuclear mask was then dilated to cover as much of the cytoplasm region 
as possible without going outside the cell boundary. Removal of the original nuclear region from 
this dilated mask created a ring mask in the cytoplasm region outside the nuclear envelope. The 
number of pixels away from the nuclear mask (1 pixel) and the number of pixels (width = 3 
pixels) between the inner and outer ring masks were selectable within the TA bio-application 
software. The ring masks were then used to quantify the amount of target channel GR-GFP 
fluorescence within the cytoplasm region. The TA image analysis algorithm outputs quantitative 
data including; the total selected object or cell counts (SCC) from Ch1, the total and average 
fluorescent intensities of the GR-GFP in the nuclear (Circ) or cytoplasm (Ring) compartments of 
the cell. To quantify the relative distribution of the GR-GFP within the nucleus and the 
cytoplasm regions of the 3617.4 cells the TA image analysis algorithm provides a mean average 
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intensity difference calculated by subtracting the average GR-GFP intensity in the Cytoplasm 
(Ring) region from the average GR-GFP intensity in the Nuclear (Circ) region of Ch2 to produce 
a MCRAID-Ch2. 
2.2.2.4 Indirect Immuno-fluorescent staining of 3617.4 cell MTs 
To visualize the organization of microtubules in images of 3617.4 cells acquired on the AS-VTI 
we adapted previously described indirect immuno-fluorescence sample preparation methods 
(Trask et al., 2009). Briefly, fixed Hoechst stained 3617.4 cells prepared as described above for 
the GR-GFP translocation HCS assay were permeabilized in 0.5% (v/v) Triton X-100 in PBS 
(without Ca2+ and Mg2+) for 5 minutes at ambient temperature, cells were washed once in PBS 
(without Ca2+ and Mg2+) and then incubated for 15 min in 0.1% (v/v) Tween 20 in PBS (without 
Ca2+ and Mg2+) blocking buffer, cells were incubated for 1 hr with a 1:2000 dilution of a mouse 
monoclonal anti-α-tubulin antibody PBS (without Ca2+ and Mg2+). Cells were then washed once 
in PBS (without Ca2+ and Mg2+) and then incubated for 15 min in Tween 20 blocking buffer and 
then incubated for 45 min with a 1:1000 dilution of goat anti-mouse IgG antibody conjugated to 
Alexa-595 in PBS (without Ca2+ and Mg2+). Cells were then washed twice with 50 µL PBS 
(without Ca2+ and Mg2+) and sealed with the last 50 µL wash of PBS in place.  Fluorescent 
images from three fluorescent channels were then sequentially acquired on the AS-VTI using a 
20x 0.4NA objective with the XF53 (Hoechst and FITC) and the XF32 (TRITC) excitation and 
emission filter sets to obtain images of stained nuclei, GR-GFP and anti-α-tubulin antibody 
stained MTs.   
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2.2.3 Glucocorticoid Receptor Competition Binding Assay 
The GR competitor assays were performed according to the manufacturer’s (Invitrogen, 
Carlsbad, CA) recommendations with the final sample volume reduced to 40 μL.  Human 
recombinant GR was used at the recommended concentration of 15 nM and Fluormone™ GS1 
was used at a concentration of 1 nM.  An initial screen was performed with aliquots (20 µL) of 
the mixture of test compounds in DMSO screening buffer with final concentrations of 12.5 and 
50 μM were distributed in 384-well, black flat-bottom plates.  4X Fluormone™ (10 µL) followed 
by 4X GR (10 µL) was then added to the wells.  Each compound was tested in triplicate, and 
50 μM dexamethasone was used as a positive control.  The DMSO concentration was kept at 1% 
(v/v) throughout the experiment.  After 2 h, the fluorescence polarization (485 nm excitation and 
530 nm emission) was measured using a SpectraMax®
2.2.4 ATPase Activity Inhibition Assays 
 M5 Microplate Reader.  Data was then fit 
to a one-site competition curve using KaleidaGraph Software V.4.03.  The fit was constrained by 
the high polarization control, which was the GR/GS1 complex with no competition, and the low 
polarization control, which was the GR/GS1 complex with 50 µM dexamethasone for 100% 
competition.   
2.2.4.1 Cytoplasmic Dynein 
Test agents at 10 and 50 µM or DMSO were added to buffer consisting of 20 mM Tris-HCl, pH 
7.6, containing 50 mM KCl, 5 mM MgCl2 and 28 nM dynein was incubated for 15 min on ice.  
A positive control was performed using 100 µM sodium orthovanadate.  Separately, 
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microtubules were preformed by incubating 10 µM bovine tubulin with 10 µM PTX in 1 M 
MSG, pH 6.6, at 37 °C for 30 min.  The preformed MTs were then centrifuged at 17,000g for 30 
min at 37 °C.  The pellet was resuspended in the same buffer used for cytoplasmic dynein with 
10 µM paclitaxel and incubated for an additional 20 min while maintaining samples at 37 °C.  
Then, 1 mM ATP was added to the sample mixtures and were incubated at 37 °C for 30 min with 
or without preformed microtubules for a final volume of 50 µL per well of a 384-well clear, flat-
bottom plate.  The amount of free phosphate was detected using a modified malachite kit 
(PiColorlock™ Gold Assay) according to the manufacturer’s protocol. Samples were then read 
with a SpectraMax®
2.2.4.2 Hsp70 
 M5 Microplate Reader at 630 nm.  The absorbance of an ATP blank was 
subtracted from all sample readings.  Amount of activity inhibition was calculated by the amount 
of absorbance normalized to DMSO control: Percent inhibition = (1-(absorbance of sample with 
test agent/absorbance of sample with DMSO))*100.   
Ssa1p (1300 nM) was incubated on ice with test agents at 10 and 50 µM or DMSO for 15 min in 
buffer consisting of 50 mM HEPES, pH 7.2, containing 2 mM MgCl2.  Sodium orthovanadate 
(100 µM) was used as the positive control.  Then 1 mM ATP was added to the sample mixtures 
and were incubated at 32 °C for 1 h for a final volume of 30 µL per well of a 384-well clear, flat-
bottom plate.  The amount of free phosphate was detected and activity inhibition was performed 
as described above (2.2.4.1).   
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2.2.4.3 Hsp90 
Hsc82p (1300 nM) was incubated on ice with test agents at 10 and 50 µM or DMSO for 15 min 
in buffer consisting of 20 mM Tris-HCl, pH 7.4, containing 2 mM MgCl2
2.2.4.4 Myosin 
.  17-AAG (50 µM) 
was used as the positive control.  Then, 1 mM ATP was added to the sample mixtures and were 
incubated at 32 °C for 1 h for a final volume of 30 µL per well of a 384-well clear, flat-bottom 
plate.  The amount of free phosphate was detected and activity inhibition was performed as 
described above (2.2.4.1).   
Rabbit skeletal muscle myosin II (125 nM) and the test agents at 10 and 50 µM were premixed in 
50 mM Tris-HCl, pH 7.9, containing 0.23 M KCl and 2.5 mM CaCl2, 
2.2.5 Microtubule Polymerization Assay 
then incubated on ice for 
15 min.  Then, 1 mM ATP was added to give a final volume of 50 µL per well of a 384-well 
clear, flat-bottom plate.  N-Ethylmaleimide (100 µM) was used as the positive control.  The 
reaction mixture was incubated at room temperature for 30 min.  The amount of free phosphate 
was detected and activity inhibition was performed as described above (2.2.4.1).   
Microtubule polymerization was measured by the change in absorbance of the solution at 340 nm 
with a SpectraMax® M5 Microplate Reader.  Tubulin (or biotinylated-tubulin) at a final 
concentration of 1 mg/mL in 1 M monosodium glutamate (MSG), pH 6.6, with 400 µM GTP, at 
37 °C was used, and positive and negative controls included 10 µM PTX and colchicine (CHC), 
respectively.  The relative MT stabilization or destabilization was measured from the absolute 
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change in absorbance after 20 min normalized to the PTX or CHC absorbance, respectively, also 
at the 20 min time point. 
2.2.6 Optical Biosensors 
2.2.6.1 Tubulin Biotinylation  
Purified tubulin was biotinylated with 20-fold molar excess (50 mM) EZ-Link NHS-LC-Biotin 
diluted in DMSO following the manufacturer’s procedures in 0.1 M MES, pH 6.9.  Samples 
were then incubated on ice in a cold room for 2 h.  Unreacted biotin was removed by membrane-
based size exclusion filtration via centrifugation in a 30 kDa Nanosep (PALL Corp., Portsmouth, 
Hants, UK) microcentrifuge tube four times for 4 min at 5000g and 4 °C (Jouan BR4i AB-2.14 
rotor), washing the sample with 0.1 M MES buffer after each spin.  The concentration of the 
biotinylated protein was determined with a BCA Protein Assay kit and the activity was tested as 
described above (2.2.4).  
2.2.6.2 Biosensor Surface Functionalization 
Dual Polarization Interferometry Chip  
NHS-LC-biotin (Pierce, Chester, UK) (200 mM in DMSO) was dropped onto the channels of an 
Amine AnaChipTM (Farfield Group Ltd, Crewe, UK) ex situ for 10 min. The channels were then 
rinsed with deionized water before inserting into the chip manifold of an AnaLight® DPI 
instrument (Farfield Group Ltd, Crewe, UK).  The chips were pre-equilibrated with 0.1 M MES, 
pH 6.9 running buffer.  Streptavidin was injected at 35 µL/min for 4 min followed by an 
injection of biotinylated tubulin at the same rate and time period.  After each injection, the flow 
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was returned to running buffer for a given time period so that unbound molecules were washed 
from the chip and the baseline was stabilized.   
 
Resonant Mirror Cuvette  
A biotin cuvette (NeoSensors, Ltd., UK) was used as the base for the biotin-tubulin surface for 
experiments monitored by the IAsys RM instrument (NeoSensors, Ltd., UK).  The volume of 
sample used during all steps of the experiment was 30 µL. Streptavidin (50 µg) was added to a 
cuvette containing 10 mM phosphate buffer, pH 7.7 and incubated for approximately 20 min or 
until a response of ~2000 arcseconds was obtained (1 arcsecond = 1/3600°; 600 arcseconds 
corresponds to 1 ng/mm2
2.2.6.3 Microtubule Polymerization on Biosensor Surfaces 
 protein on the sensor surface).  The phosphate buffer was removed 
from the cuvette, which was then washed and filled with 1 M MSG, pH 6.6 buffer.  
Approximately 50-60 µg of biotinylated tubulin was added to the cuvette for 10-15 min and the 
bound tubulin was washed with MSG buffer.  For re-use, cuvettes were stripped with 12.5 M 
KOH for 20 s, which removes all the bound streptavidin, and rinsed with water before a new 
layer of streptavidin was formed. 
Dual Polarization Interferometry Biosensor  
An injection of 1 M MSG, pH 6.6 with 400 µM GTP was performed at 35 µL/min for 2 min to 
subtract the relative bulk shift due to MSG when the sample was injected.  Tubulin (1 mg/mL) in 
the MSG buffer was then injected continuously at 35 µL/min for 45 min by replacing the 
standard sample loop with a 5 mL sample loop.  Data was resolved with the AnaLight Resolver® 
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Software using the MSG, water, and 4:1 ethanol-water (w/w) injections with the instrument set at 
37 °C for calibration as described by Swann et al. (2003). 
 
Resonant Mirror Biosensor 
After the addition of biotinylated tubulin, the cuvette was washed with 1 M MSG, pH 6.6 with 
400 µM GTP.  Approximately 70 µg of tubulin was then added to the cuvette and the change in 
response was monitored.  When testing temperature dependence and the effect of compounds on 
initial rates of assembly, a mixture of sample buffer ± 10 µM of various MT stabilizers and 
destabilizers was added before the addition of tubulin.  In one instance, tubulin was pre-
incubated on ice with CHC for 15 min before addition to the cuvette. The stirrer setting on the 
instrument was maintained at 70%, while the temperature was set at 37 °C.  
2.2.7 Computational Modeling 
2.2.7.1 Secondary Structure Prediction 
The sequence of rat cytoplasmic dynein heavy chain 1 from Gly1286-Glu4644 was submitted to 
NetSurfP ver. 1.1 (Petersen et al., 2009) for secondary structure (alpha helix, beta sheet, random 
coil) prediction and to Real-SPINE 3.0 (Faraggi et al., 2008) for dihedral angle (Φ,Ψ) prediction.  
The sequence was also submitted to DISULFIND (Ceroni et al., 2006) for prediction of disulfide 
connectivity. 
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2.2.7.2 Three-Dimensional Comparative/Homology Modeling 
The sequence of rat cytoplasmic dynein heavy chain 1 from Gly1286-Glu4644 was aligned with 
the sequence of the previously reported models of cytoplasmic dynein’s motor domain with the 
PDB files 2GF8 (Serohijos et al., 2006) and 1HN5 (Mocz and Gibbons, 2001) using the 
ClustalW2 program (EMBL-EBI).  This sequence alignment was then used to generate 3D 
models using MODELLER 9v8 (Eswar et al., 2006).  Based on the sequence alignment 
produced, the rat cytoplasmic dynein heavy chain 1 sequence was shortened to Tyr1866-
Pro3121, Ala3450-Ala3461, and Leu3551-Glu4644 in order to facilitate the best match between 
the rat cytoplasmic dynein heavy chain 1 bases and the ATOM records from the PDB files 2GF8 
and 1HN5.  3D models based on the truncated sequence were generated using MODELLER 
using PDB files 2GF8 and 1HN5 as a reference individually and then combined.  For each of the 
aforementioned procedures MODELLER created five PDB files each and the best model of each 
procedure was selected based on the lowest Discrete Optimized Protein Energy (DOPE) score.  
2.2.8 Cysteine Labeling 
Labeling of cysteine residues of dynein and BSA samples was monitored using the maleimide-
based fluorescent dye methyl-10-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-9-methoxy-3-oxo-3H-
benzo[f]chromene-2-carboxylate (ThioGlo1®), referred to hereon as TG1.  A 2-fold increment 
concentration range of 0.18-0.72 µM of protein in 10 mM PBS, pH 7.4, was incubated with TG1 
at a final concentration of 10 µM and in the presence and absence of 2% (w/v) SDS for 1 h in the 
dark at room temperature.  Fluorescence emission of cysteine–TG1 protein adducts was recorded 
of 80 µL samples in a black, flat-bottom Costar® 384-well plate (Corning, Inc.) using excitation 
and emission wavelengths of 379 and 513 nm, respectively, using a Spectramax® M5 Microplate 
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Reader.  The slope of a concentration curve of glutathione incubated with excess TG1 was used 
to calibrate the absolute amount of thiols in dynein and BSA samples.  
For sequence identification of labeled peptides, protein samples were labeled with 10 µM 
TG1 for 1 h at room temperature in the dark before a 3 kDa NMWL Microcon®
2.2.9 Protein Digestion 
 filter-based 
centrifugation device was used to remove excess TG1.  Protein sample added to the reservoir and 
the centrifugal device was spun at 14,000g for 8 min.  The retentate was diluted with 300 µL 50 
mM Tris-HCl, pH 7.2 buffer and sample was centrifuged for 12 min at 14,000g.  The device was 
inverted into a clean vial and centrifuged for 2 min at 1,000g to collect sample for MS analysis.  
2.2.9.1 In-gel Trypsin Digestion  
Individual protein bands were excised from gels and placed in microcentrifuge Eppendorf tubes 
containing 1:1 acetonitrile (CH3CN) in 25 mM ammonium bicarbonate (NH4HCO3), pH 7.8, 
solution and were gently agitated overnight to remove Coomassie stain.  The supernatant was 
removed and replaced with fresh solution for another 2 h to remove any remaining Coomassie 
stain.  Where indicated, gel pieces were reduced by adding a solution of 10 mM tris(2-
carboxyethyl)phosphine (TCEP) for 30 min at 37 °C.  Reducing solution was then replaced with 
50 mM iodoacetamide (IAC) for 45 min at 56 °C for alkylation.  Alkylating solution was then 
removed and the gel pieces were washed with 25 mM NH4HCO3, pH 7.8, while vortexing for 10 
min.  Regardless of whether reduction and alkylation steps were performed, gel pieces were then 
washed with 100% CH3CN until plugs were completely white.  The CH3CN was removed and 
gel pieces were air dried for 10 min.  Gel pieces were then rehydrated with 10 µL (20 ng/µL) 
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trypsin solution or enough to cover gel pieces for 15 min on ice.  Excess trypsin was removed 
and 30 µL of 25 mM NH4HCO3 to keep gel pieces immersed throughout digestion.  Gel pieces 
were incubated for 12 h at 37 °C.  The digestion was quenched by adding 5 µL of 5% aqueous 
formic acid (HCO2H).  The supernatant was removed and placed in a new tube.  Peptides were 
extracted from the gel pieces by adding a 70% CH3CN, 25 mM NH4HCO3, 5% HCO2H solution 
and sonicating for 10 min.  Extraction was repeated three times and the supernatants were pooled 
together with the original supernatant.  The extract was dried to completeness using a centrifugal 
evaporator (SpeedVac).  The pellet was resuspended in 25 mM NH4HCO3 with 1% HCO2
2.2.9.2 In-solution CNBr Digestion 
H for 
MS and MS/MS analyses.  
Protein samples were dried with a SpeedVac and then resuspended in 200 µL of 70% HCO2H in 
glass vials for in-solution digestion with cyanogen bromide (CNBr).  Samples were handled with 
extra care in the fume hood for safety purposes.  Approximately 2-3 CNBr crystals were 
dissolved into the solution and N2 gas was gently blown for 15 s into the vials before they were 
capped and placed in the dark overnight at room temperature.   The reaction was quenched by 
adding 1 mL of H2O and drying the sample with a SpeedVac.  Samples were resuspended in 25 
mM NH4HCO3 and then desalted with a C18 ZipTip®
2.2.10 Mass Spectrometry 
 (Millipore). 
2.2.10.1 MALDI-TOF-MS and -MS/MS 
For MS analysis, 0.5 µL of extract was spotted onto a stainless steel target and allowed to air dry.  
A 0.5 µL aliquot of a 10 mg/ml solution of 〈-cyano-4-hydroxycinnamic acid (CHCA) dissolved in 
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CH3
2.2.10.2 LC-ESI-MS 
CN was then applied atop of the peptide spot and then allowed to air dry.  MALDI-TOF and 
MALDI-TOF/TOF mass spectra were recorded with an Applied Biosystems 4800 Proteomics 
Analyzer (ABI, Foster City, CA) in the reflectron positive ion detection mode.  MS spectra were 
acquired from m/z 800 to 4000 with a focus mass of m/z 2000.  MS processing was done using 
the angiotensin II internal standard by matching 6 individual peaks.  Up to 20 precursor peaks 
per spot were selected for MS/MS analysis starting from the strongest precursor with a 20 S/N 
cutoff.  Peptide CID (air) was performed at 2 kV and with a laser intensity setting of 4400.  
Peaks were submitted through the ProteinPilot Software 3.0 to the MSDB protein database 
using the MASCOT method, searching the mammalian taxonomy with six maximum missed 
trypsin cleavages and variable modifications including cysteine carbamidomethylation and 
methionine oxidation.  
Samples were injected onto a C18 PepMap100 column (I.D. 300 µm, length 15 cm, 3 µm 
particles, 100 Å pore size) (LC Packings, Dionex), which was pre-equilibrated with a solution of 
2.5% CH3CN and 0.1 % HCO2H on an UltiMate® 3000 Rapid Separation LC System (LC 
Packings, Dionex) at a flow rate of 3.5 µL/min.  Elution of sample was first directed to waste for 
the first 2 min to desalt samples.  After 2 min, the valve was changed so that eluates were 
directed to the ESI needle of a micrOTOF (Bruker Daltonics) MS.  An organic solvent gradient 
was applied to the LC column beginning with an increase from 2 to 5% of an 80% CH3CN, 0.1% 
HCO2H solution over 2 min followed by a rapid increase to 45% of the solution over another 2 
min.  The gradient was then slowly increased to 100% of the 80% CH3CN, 0.1% HCO2H 
solution over 80 min followed by a decrease to 20% for a final 10 min.  The mass detection 
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range was set between m/z 500-3000 in positive ion detection mode.  Selected mass spectra were 
then deconvoluted using the SUM PEAK algorithm selected for large peptides/proteins with a 
S/N cutoff of 10 and a minimum of 3 peaks to be considered a component and can be extracted 
from the original spectrum.  
2.2.10.3 LC-ESI-FTMS 
Samples were injected onto a C18 Acclaim PepMap100 column (I.D. 75 µm, length 15 cm, 3 µm 
particles, 100 Å pore size) (LC Packings, Dionex), which was pre-equilibrated with a solution of 
2% CH3CN and 0.1 % HCO2H on an UltiMate® 3000 Rapid Separation LC System (LC 
Packings, Dionex) at a flow rate of 200 nL/min.  Elution of sample was first directed to waste for 
the first 4 min to desalt samples.  After 4 min, the valve was changed so that eluates were 
directed to the nano-ESI needle of a 12T FT-ICR (Bruker Daltonics) MS.  An organic solvent 
gradient was applied to the LC column beginning with 4% of a 100% CH3CN, 0.1% HCO2H 
solution over 5 min followed by an increase to 50% of the solution over 25 min.  The gradient 
was then increased to 80% of the 100% CH3CN, 0.1% HCO2H solution over 0.1 min and 
maintained for 5 min.  The gradient was then returned to 4% of the 100% CH3CN, 0.1% HCO2
2.2.10.4 LC-ESI-MS/MS 
H 
solution for a final 10 min.  The mass detection range was set between m/z 184.26-3000.  
Selected mass spectra were then deconvoluted using the SNAP 2.0 algorithm selected for large 
peptides/proteins with a S/N cutoff of 10 and a minimum of 3 peaks to be considered a 
component and can be extracted from the original spectrum. 
Tryptic digests were analyzed by reversed-phase liquid chromatography (LC)-MS/MS using a 
nanoflow LC (Dionex Ultimate 3000, Dionex Corporation, Sunnyvale, CA) coupled online to an 
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LTQ-Orbitrap MS (ThermoFisher).  Separations were performed using 75 µm i.d. x 360 o.d. x 
20 cm long fused silica capillary columns (Polymicro Technologies, Phoenix, AZ) slurry packed 
in house with 5 µm, 300 Å pore size C-18 silica-bonded stationary phase (Jupiter, Phenomenex, 
Torrance, CA).  Following sample injection onto a C-18 trap column (Dionex), the column was 
washed for 3 min with mobile phase A (2% CH3CN, 0.1% HCO2H) at a flow rate of 30 µL/min.  
Peptides were eluted using a linear gradient of 0.33% mobile phase B (0.1% HCO2H in 
CH3
The MS was operated using a high resolution (R=60,000 at m/z 400) full MS scan 
conducted in the Orbitrap followed by tandem MS of the top thirteen most abundant peptide 
molecular ions by collision-induced dissociation (CID) using a normalized collision energy of 
35%.  Data were collected over a broad precursor ion selection scan range of m/z 375-1800 with 
the lock mass feature enabled using a polydimethylcyclosiloxane (PCM) ion generated in the 
electrospray process (m/z 445.120025) (Olsen et al., 2005) and an applied voltage of 1.8 kV.  
Dynamic exclusion was enabled to minimize redundant selection of peptides previously selected 
for CID (repeat count of 2, sixty second exclusion duration).  
CN)/minute for 130 min, then to 95% B in an additional 15 min, all at a constant flow rate 
of 200 nL/min.  Column washing was performed at 95% B for 15 min after which the column 
was re-equilibrated in mobile phase A prior to subsequent injections.  
Tandem mass spectra were searched against the rat dynein UniProt sequence (P38650; 
version 87, 06-15-2010; http://www.uniprot.org), using SEQUEST (ThermoFisher Scientific).  
Peptides were searched for methionine oxidation with a mass addition of 15.9949 Da and 
cysteine modification by the ThiGlo1 reagent with the following potential masses: 365.0473, 
379.0692, 383.0641 and 397.0798 Da.  Peptides were considered legitimately identified if they 
met specific charge state and proteolytic cleavage-dependent cross correlation scores of 1.9 for 
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[M+H]1+, 2.2 for [M+2H]2+ and 3.5 for [M+3H]3+
2.2.11 Electron Microscopy 
 with no delta correlation constraint given the 
single protein database search.  All labeled peptide spectra were manually inspected to verify the 
matched ions and confirm the identification. 
Carbon-coated copper electron microscopy grids were first glow-discharged for 15 s.  Protein 
samples of approximately 1 mg/mL were diluted between 1/100 - 1/20 fold with 10 mM PIPES, 
10 mM HEPES, pH 7.2, and approximately 2 µL was spotted onto copper grids for 30 s.  Excess 
sample was blotted off using a filter paper.  Grids were then floated for 30 s atop a drop of either 
1% (w/v) uranyl acetate (UO2Ac2•2H2O, UAc), 2% (w/v) ammonium molybdate 
((NH4)6Mo7O24•4H2O), or 2% (w/v) phosphotungstic acid (H3PW12O40•24HO, PTA).  Excess 
stain was blotted with filter paper from the grids.  Samples were then observed with an FEI 
Tecnai T12 electron microscope with a lanthanum hexaboride (LaB6) cathode operating at 120 
kV and equipped with a Gatan UltraScan 1000 
 
CCD camera (2048x2048 pixels in area, each 
pixel 14um x 14um).  
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3.0  IDENTIFICATION OF SMALL MOLECULES THAT TARGET RETROGRADE 
TRANSPORT 
3.1 INTRODUCTION 
The motor protein cytoplasmic dynein transports many important cargos along microtubules in a 
retrograde manner; the minus end of most microtubules is the microtubule organizing center (aka 
centrosome), near the nuclear pore.  The nucleus, where many of these cargos are often 
imported, is the site where some cargo signal for a cascade of events, including transcription and 
subsequent translation of proteins involved in a number of different cellular roles (Galigniana et 
al., 2004).  Retrograde transport is often also hijacked by microbes and viruses in their host cell 
infection process (Dohner et al., 2002; McDonald et al., 2002).  Additionally, cytoplasmic 
dynein plays important roles in crucial cellular events including mitosis (Vaisberg et al., 1993), 
chromosome segregation (Sharp et al., 2000), and cytokinesis (Yeh et al., 1995).  Because 
cytoplasmic dynein contributes to so many important cellular processes, small molecules that 
perturb dynein function would provide useful chemical and cell biology tools to further 
investigate the critical roles of cytoplasmic dynein in the cell.  To date, there are only a handful 
of small molecules that perturb cytoplasmic dynein’s functions, most of which are either 
ATP/transition state mimics (e.g., erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA), AMP, 
orthovanadate) (Bouchard et al., 1981; Vallee and Shpetner, 1990) or sulfhydryl-reactive agents 
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(e.g., thiourea, N-ethylmaleimide (NEM)) (Blum et al., 1979; Vallee and Shpetner, 1990).  The 
Day lab has previously examined purealin, a natural product derived from the sea sponge 
Psammaplysilla purea, known to enhance the ATPase activity of myosin (Takito et al., 1986) 
while also inhibiting the ATPase activity of axonemal dynein 
The Day lab therefore decided that the screening approach should be altered so that only 
cell-active hits would be identified in the initial screen.  The glucocorticoid receptor (GR) is a 
cargo of cytoplasmic dynein and is, upon agonist activation, transported along MTs to the 
nucleus.  GR is linked to cytoplasmic dynein through interactions with dynactin and 
immunophilin-heat shock protein complexes (Pratt et al., 2004).  Once agonist-bound GR 
reaches the nucleus, it then acts as a transcription factor for genes responsible for both 
upregulating and downregulating the expression of proteins involved in inflammatory and 
immune responses (Glass and Saijo, 2010).  Because GR translocation to the nucleus is agonist-
dependent, GR translocation is a recognized model for retrograde transport studies (Pratt et al., 
2004).  By using a cell-based high-information content screening (HCS) assay to quantify the 
agonist-induced translocation of GR from the cytoplasm to the nucleus as a cellular model of 
dynein-mediated cargo transport, the Day lab in collaboration with Dr. Paul Johnston (University 
of Pittsburgh Drug Discovery Institute) recently identified several concentration-dependent 
inhibitors in a library screen of small molecules.  First, the distribution of glucocorticoid 
receptor-green fluorescent protein (GR-GFP) present in the cytoplasm and nuclei of cells was 
examined and compared to determine the compounds that inhibited agonist-induced GR 
(Fang et al., 1997).  The Day lab 
found that racemic purealin and some synthetic analogues inhibited the ATPase activity of rat 
cytoplasmic dynein heavy chain 1 (Zhu et al., 2006); although purealin itself is a potent inhibitor 
of cytoplasmic dynein heavy chain in vitro, the compound does not exhibit such action in cells. 
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translocation.  From these same images, the cellular toxicity of compounds was evaluated, 
defined by a loss of cells, as were compound-induced changes in the morphology of α-tubulin 
antibody staining, along with the intensity and the overall MT organization of treated cells.   
I then developed and optimized secondary biochemical assays to characterize the cell-
based assay hits and to investigate the potential mechanisms of action of these inhibitors of 
cytoplasmic dynein-mediated cargo transport.  GR competitive binding and MT polymerization 
assays in vitro were performed to identify potential GR binding antagonists and MT perturbing 
agents, respectively.  Compounds were then tested against the ATPase activity of Hsp90 and 
Hsp70 molecular chaperones, which are both important components of the GR cargo transport 
process.  The ability of the GR translocation inhibitors to inhibit both the basal and the MT-
stimulated ATPase activity of recombinant cytoplasmic dynein heavy chain 1 motor domain was 
then tested.  Finally, to evaluate the ATPase selectivity of the hits, compounds were screened 
against the ATPase activity of the myosin molecular motor, since the only known inhibitor of 
dynein (purealin; vide supra) has also been shown to specifically alter myosin’s ATPase activity.  
Once each of the described assays were validated and optimized using a number of compounds 
from the Sigma LOPAC collection, the assays were performed on a larger subset of compounds 
from the MLSCN collection.  
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3.2 RESULTS & DISCUSSION 
3.2.1 High Information Content Cell-Based Screen 
Multi-parameter immunofluorescence microscopy was first utilized to provide high-content 
information on the cellular effects of the compounds on cells expressing GR-GFP.  Such an 
analysis provides information on the location of GR-GFP within the cell, as well as effects on 
MT mass, nuclear morphology, and cytotoxicity by surveying different components of the cell 
with specific labels: in this case GR-GFP, tubulin antibodies, and Hoechst (Figure 16).  This was 
performed in a concentration-dependent manner to determine an ideal concentration to test 
compounds for inhibition of GR-GFP translocation before results were attributed to cytotoxic 
effects (Figure 16).  The difference in the GR-GFP signal between the nuclei and the cytoplasm, 
or mean circ-ring average intensity difference (MCRAID), indicated the inhibition of 
dexamethasone-induced GR-GFP translocation with all of the compounds tested.  The number of 
cells was determined from the number of circular Hoechst-stained objects, while MT mass was 
determined from the intensity of antitubulin antibody fluorescence in the ring (cytoplasmic) 
surrounding the circles (nuclei).  Inhibition of GR-GFP translocation in cells appeared to be 
concentration-dependent and this analysis also revealed maximally tolerated concentrations of 
compounds before significant cytotoxicity was observed.  Upon analysis of the hits from the 
1280 LOPAC screen, Bay 11-7085 exhibited the most significant cell toxicity at higher 
concentrations than did any of the other compounds, but still inhibited GR translocation at lower, 
non-cytotoxic concentrations (around 12.5 µM).  Unlike Bay 11-7085, calcimycin and 
GR(127935) HCl hydrate were toxic at even low concentrations and were deemed undesirable 
for further HCS studies but were still evaluated in the biochemical assays.    
 66 
 
Figure 16. Cell-Based Concentration Dependence of LOPAC Collection on GR-GFP Translocation 
A) Mean circ-ring average intensity difference indicates the amount of GR-GFP in the nucleus compared to 
the cytoplasm as a function of concentration with less GR-GFP present in the nuclei at higher concentrations of 
compound.  B) Mean ring average intensity indicates the amount MTs present surrounding nuclei with Bay 11-7085 
being the only compound demonstrating fewer MT masses at higher concentrations of compound.  C) Mean cells 
counts indicate the cyotoxic effects of compounds with Bay 11-7085 being cytotoxic at concentrations greater than 
12.5 µM.  Graphs provided by Sunita Shinde and Dr. Paul Johnston.  
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Upon evaluation of the images of treated cells, the cellular phenotype of the DMSO 
control demonstrated well-organized cells with a few cells undergoing mitosis and diffuse GR-
GFP located predominantly in the cytoplasm (Figure 17).  The cells were also uniformly rounded 
with numerous sizeable cellular projections.  Upon the addition of the GR agonist 
dexamethasone (DEX), the cell morphology appeared very similar to the DMSO control with the 
exception that all of the GR-GFP had translocated into the nuclei, as expected.  A total of 7 
compounds from the 1280 Sigma LOPAC screen that were incubated 60 min prior to DEX 
treatment noticeably decreased the GR-GFP content within nuclei relative to the DEX control.  
These compounds did not show any significant differences in cell counts and MT masses 
compared to the DMSO control, but still caused considerable inhibition of GR-GFP 
translocation.  Parthenolide, along with apomorphine, Bay 11-7085, and 4-phenyl-3-
furoxancarbonitrile, all appeared to alter cell morphology and MT organization, indicating they 
interfered with dynein-mediated translocation.  Most noticeably, there was excess accumulation 
of GR-GFP in the cytoplasm along with fewer and shorter cellular projections protruding from 
the nuclei.   
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Figure 17. Multi-Parameter Immunofluorescence Visualization of Treated Cells 
GR-GFP (green) was used to track cytoplasmic dynein translocation, a fluorescent tubulin antibody (red) to 
label MTs, and Hoechst 33342 was used to label DNA (blue) to visualize the nuclei.  Images provided by Sunita 
Shinde and Dr. Paul Johnston.  
 
The immunofluorescence of the individual components from the images was also 
quantified (Figure 18).  The difference in the GR-GFP signal between the nuclei and the 
cytoplasm (MCRAID) indicated the inhibition of DEX-induced GR-GFP translocation with all 
of the compounds tested compared to the DEX control.  MT mass and cell counts were also 
quantified and demonstrated comparable values to the DMSO and DEX controls, with the 
exception of Bay 11-7085.  
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Figure 18. Quantitation of Multi-Parameter Immunofluorescence in Cells Treated with LOPAC 1280 Hits 
A) Mean circ-ring average intensity difference indicates the amount of GR-GFP in the nucleus compared to 
the cytoplasm with all compounds demonstrating decreased GR-GFP in nuclei relative to the DEX control.  B) 
Mean ring average intensity indicates the amount of MTs present surrounding nuclei with Bay 11-7085 being the 
only compound demonstrating fewer MT masses.   C) Mean cells counts indicate the cytotoxic effects of compounds 
being negligible compared to the DMSO control with the exception of Bay 11-7085.  Quantitation of images 
performed by Sunita Shinde and Dr. Paul Johnston.  
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Since GR translocation is dependent on agonist binding (Galigniana et al., 1998), 
association with Hsp chaperones, an intact cytoskeleton (Harrell et al., 2004), and manifestly 
cytoplasmic dynein activity, a number of biochemical assays were performed to evaluate the 
target(s) of these small molecules that caused inhibition of GR-GFP accumulation in the nuclei 
of cells (Figure 19).   
 
Figure 19. Four of the Potential Target(s) of Retrograde Transport Inhibitors 
Small molecules can inhibit the transport of GR to the nucleus by either preventing direct binding of 
agonist to GR, inhibition of either Hsp 70 or 90 necessary for dynein-cargo complex formation, perturbation of MT 
dynamics necessary for dynein translocation, and direct inhibition of cytoplasmic dynein ATPase activity.  
Cytoplasmic dynein translocation can also be inhibited by disruption of other proteins or protein-protein interactions 
necessary for complex formation including dynactin and immunophilins [adapted from Pratt et al. (2004) with 
permission from publisher].  
3.2.2 Biochemical Characterization of GR-GFP Translocation Inhibitors 
3.2.2.1 Glucocorticoid Receptor Competitive Binding 
The ability of GR-translocation inhibitors to compete with and disrupt the binding of a 
fluorescent-labeled ligand to the GR was investigated using a fluorescence polarization (FP) 
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binding assay.  In the FP assay, dexamethasone inhibited ligand binding in a concentration-
dependent manner (Figure 20A) and exhibited an IC50 value of 10.1 ± 1.5 nM, which compares 
well to previously published values (Reynolds et al., 1997).  At the two concentrations tested 
against the LOPAC collection, 12.5 µM and 50 µM, neither parthenolide nor 4-phenyl-3-
furoxancarbonitrile disrupted the binding of the agonist to GR in the FP binding assay (Figure 
20B).  At 50 µM, all of the remaining GR-translocation inhibitors appeared to disrupt GR 
binding by an average of > 60%. At 12.5 µM (Figure 20B), however, the percent inhibition of 
GR-binding for most of these compounds was considerably lower.  Given the large standard 
errors in the compound binding data it is unclear whether the apparent disruption of GR binding 
at high concentrations contributes to the inhibition of DEX-induced GR translocation observed at 
compound concentrations lower than 12.5 µM.   
 
Figure 20. Fluorescence Polarization GR Competitive Binding Assay 
A) Concentration dependent evaluation of the competitive binding of the GR agonist DEX fitted by a one-
site competition curve with an IC50 value of 10.1 nM.  B) Percent competition of test compounds against binding to 
GR normalized to DEX control.  Data represented as mean values with SD from six independent measurements. 
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Once methods were established with the LOPAC collection, a large subset (69) of 
compounds from the MLSCN that inhibited GR-GFP translocation was also tested for 
competitive binding to GR at an intermediary concentration of 20 µM.  Other hits from the 
MLSCN screen were disregarded from secondary screening due to their poor pharmacological 
properties.  At this concentration, only six out of the 69 compounds tested exhibited competition 
greater than 50% (Figure 21).  This was an indication that perhaps the remaining 63 compounds 
had other targets within the cell responsible for inhibiting GR translocation.  A small number of 
compounds also appeared to have negative percent competition values, most notably compound 
#23.  Given that this assay relies on the anisotropy a fluorescent molecule that binds to the GR 
ligand binding domain, it is unlikely that these results are indicative of enhanced binding, but 
rather due to protein precipitation or aggregation in the presence of that particular compound.  
 
Figure 21. GR Competitive Binding Assay with MLSCN Collection 
Percent competition of test compounds against binding to GR normalized to DEX control.  Six out of a 
total of 69 compounds exhibited competition >50% (chemical structures shown in Appendix A).  Data represented 
as mean values with SD from three independent measurements. 
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3.2.2.2 Targeting the Cellular Tracks 
Since retrograde transport requires the existence of functionally structured MTs (Galigniana et 
al., 1998) alterations in MTs can stall GR translocation by cytoplasmic dynein.  Many 
compounds have been previously demonstrated to alter MT dynamics by either acting as MT 
stabilizers (PTX (Schiff et al., 1979) and DCD (Ter Haar et al, 1996)), or destabilizers (CHC 
(Bhattacharyya et al., 2008) and VCN (Jordan et al., 1985)).  MT perturbing agents have been 
shown to inhibit transport of p53 via cytoplasmic dynein to the nucleus (Giannakakou et al., 
2000).  Compounds identified as MT perturbing agents may also serve as cytoplasmic dynein 
enhancers when used at low concentrations (Giannakakou et al., 2002).  Therefore, we also 
tested the ability of the selected compounds to perturb MT dynamics relative to the MT stabilizer 
PTX and the MT destabilizer CHC (Table 1), which disrupt the ability of dynein to transport its 
cargo.  Of the eight LOPAC compounds that were tested, 4-phenyl-3-furoxancarbonitrile and 
Bay 11-7085 both exhibited MT destabilization characteristics.  4-Phenyl-3-furoxancarbonitrile 
is a nitric oxide donor (Medana et al., 1994), while Bay 11-7085 is an NF-κB inhibitor (Pierce et 
al., 1997) that induces apoptosis with no other evidence of altering MT dynamics.  Additionally, 
calcimycin showed only minor MT destabilization in vitro but has been demonstrated to cause 
blood platelet microtubules to depolymerize (Kenny and Chao, 1980).  Incidentally, 
parthenolide, a previously recognized MT stabilizer (Miglietta et al., 2004), was the only 
compound tested to induce MT polymerization in vitro.  MT perturbation measurements by 
turbidity were effective for a small number of samples, but were not robust enough for high 
throughput assays using 384-well plates as evident by the large standard deviations.  Attempts to 
resolve this issue will be discussed in the following chapter. 
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Table 1. Inhibition of GTP-induced assembly and hypernucleation/polymer stabilization of bovine 
brain tubulin by hits from the HCS analysis of the LOPAC1280 collection. 
Compound (10 µM) Percent Destabilization Relative to 10 µM CHC 
Percent Stabilization 
Relative to 10 µM PTX 
4-Phenyl-3-furoxancarbonitrile 50.71 ± 10.7 NP 
Parthenolide -26.41 ± 11.7 80.6 ± 7.9 
(R)-Apomorphine HCl hydrate -2.51 ± 54.8 NP 
(S)-Apomorphine HCl hydrate 23.81 ± 6.8 NP 
6-Nitroso-1,2-benzopyrone 42.21 ± 44.8 NP 
Calcimycin 20 ± 8.9 NP 
GR(127935) HCl hydrate 0.4 ± 19.5 NP 
Bay 11-7085 64.5 ± 27.4 NP 
Data are mean values ± SD (n=3). NP: No Polymerization. 
3.2.2.3 Targeting Hsp Chaperones 
Other factors such as the stability of the dynein-cargo complex play an important role in the 
transport of cytoplasmic dynein.  In the case of the GR, complex formation begins with the ATP-
dependent binding of Hsp70 to the GR along with the nonessential co-chaperone Hsp40 creating 
a ‘primed’ GR/Hsp70 complex (Murphy et al., 2003).  The GR/Hsp70 complex then binds to 
Hsp90 followed by the binding of p23 to stabilize this newly formed complex (Dittmar et al., 
1997).  GR translocation is dependent on its association with Hsp90 and it has been suggested 
that the dynamics of this complex is dependent on ligand binding to the receptor (Pratt et al., 
2004).  A number of Hsp-binding immunophilins then link the cargo complex to the light and 
intermediate chains of cytoplasmic dynein (Harrell et al., 2004).  Inhibition of Hsp90 with 
geldanamycin has been demonstrated to halt GR translocation (Czar et al., 1997).  Given the 
importance of the Hsps in stabilizing the cargo complex with cytoplasmic dynein, we 
investigated whether or not the targeting of these proteins inhibited GR translocation.  Ssa1p and 
Hsc82p, the yeast versions of Hsp 70 and 90, respectively were used in this study because of the 
shared homology with mammalian versions (Schlesinger, 1986) along with the fact that the 
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formation of the cargo complex is conserved among different species (Harrell et al., 2002).  
Therefore, screening for compounds that alter the ATPase activity of Hsps can indicate potential 
targets of compounds inhibiting GR translocation.  In addition, the identification of Hsp 
inhibitors/activators could prove to be useful since Hsps are a therapeutic target in oncology 
(Calderwood et al., 2006) and against neurodegenerative diseases because of their involvement 
in protein folding (Luo et al., 2010).   
Through the use of a colorimetric assay, the percent inhibition of ATPase activity was 
calculated by comparing the amount of inorganic phosphate released in the presence of the 
compounds relative to a DMSO control.  Initial ATPase experiments resulted in immediate 
protein precipitation upon addition of malachite reagents used to detect free phosphate in 
solution.  Precipitation occured even at low divalent cation (Mg2+) concentrations that could have 
interfered with the malachite reagents and free phosphate, forming water insoluble salts (Shih et 
al., 2004).  In order to overcome issues with precipitation, a modified malachite reagent was 
used further on.  A variation in DMSO concentration demonstrated that assays tolerated up to 2% 
DMSO without any significant change in absorbance (Figure 22). 
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Figure 22. DMSO Tolerance of Hsp70 ATPase Activity 
The ATPase activity of Ssa1p (Hsp70) was evaluated at different DMSO concentrations.  The maximum 
(max) signal represented the amount of free inorganic phosphate detected with modified malachite reagents upon 
hydrolysis of ATP by Ssa1p as a function of absorbance at 630 nm.  The minimum (min) signal represented the 
amount of free phosphate detected with modified malachite reagents in the absence of ATP.  The blank signal 
represents the absorbance change of buffer and modified malachite reagents due to DMSO alone.  Data represented 
as mean values with SD from three independent measurements. 
 
Ssa1p in the presence of compound concentrations greater than 10 µM caused protein 
precipitation once modified malachite reagents were added to the mixture, hindering 
measurement of ATPase activity.  Protein precipitation was also observed in the absence of 
malachite reagents by evaluating by gel electrophoresis the supernatants and pellets of protein 
incubated with compounds (Figure 23). 
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Figure 23. Evidence of Precipitation of Ssa1p Samples in the Presence of LOPAC Collection 
Compared to Ssa1p samples treated with the LOPAC collection at 10 µM, greater amount of protein 
sample was present in the pellet when samples were treated with 50 µM suggesting the presence of a precipitate 
even in the absence of added modified malachite reagents.  
 
At the highest concentration tested, 50 µM, none of the compounds had any significant 
effect on Hsc82p (the yeast homolog of Hsp90) (Figure 24).  Hsp90 has a unique ATP binding 
pocket near its N-terminus, where only specific inhibitors such as geldanamycin can bind 
(Grenert et al., 1997).  The use of 17-AAG, which is an ansamycin antibiotic that binds Hsp90 
(Neckers, 2002), as a control (Figure 3) exhibited expected inhibition of Hsp90 activity 
(Rowlands et al., 2004).  It is also apparent that GR(127935) HCl hydrate may be an Hsp90 
activator rather than an inhibitor.  
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Figure 24. Hsp ATPase Inhibition Assays with LOPAC Collection 
A) Percent inhibition of ATPase activity of Ssa1p with test compounds compared to DMSO control and 
sodium orthovanadate as a control.  B) Percent inhibition of ATPase activity Hsc82p with test compounds compared 
to DMSO control and 17-AAG as a control.  Data represented as mean values with SD from six independent 
measurements. 
 
Although testing the ATPase activity inhibition of Ssa1p with compounds from the 
MLSCN revealed 29 potential inhibitors that inhibited activity >50%, many of these results had 
extraordinarily large standard deviation values and additional replicates are required to eliminate 
any false positive results (Figure 25).  These results are due to the relatively low ATPase activity 
of hsp leading to a smaller window between maximum and minimum absorbance signals.  In 
addition, several compounds, particularly compound #23, appeared to inhibit the ATPase activity 
>100% (i.e., sample absorbance was lower than the ATP only control).  Given that percent 
inhibition >100% is not physically possible, the most likely explanation of these results is due to 
protein precipitation as experienced in earlier experiments with compounds from the LOPAC 
screen. 
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Figure 25. Hsp70 ATPase Inhibition Assay with MLSCN Collection 
Percent ATPase activity inhibition of test compounds against Ssa1p compared to an orthovanadate (OV) 
control.  Twenty-nine out of a total of 69 compounds exhibited competition >50%.  Data represented as mean values 
with SD from three independent measurements.   
3.2.2.4 Targeting Cytoplasmic Dynein  
The ability of the compounds to selectively inhibit cytoplasmic dynein’s ATP-driven motor 
activity was then investigated.  An initial DMSO tolerance assay indicated that dynein assays 
tolerated up to 5% DMSO without any significant change in absorbance (Figure 26).   
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Figure 26. DMSO Tolerance of Cytoplasmic Dynein ATPase Activity 
The ATPase activity of cytoplasmic dynein was evaluated at different DMSO concentrations.  The 
maximum (max) signal represented the amount of free inorganic phosphate detected with modified malachite 
reagents upon hydrolysis of ATP by cytoplasmic dynein as a function of absorbance at 630 nm.  The minimum 
(min) signal represented the amount of free phosphate detected with modified malachite reagents in the absence of 
ATP.  The blank signal represents the absorbance change of buffer and modified malachite reagents due to DMSO 
alone.  Data represented as mean values with SD from three independent measurements. 
 
ATPase inhibition assays were then performed on the 1280 Sigma LOPAC library with a 
baculovirus/insect cell system-expressed, 380 kDa version of cytoplasmic dynein lacking the 
stalk in both basal and MT-stimulated environments.  It is evident from Figure 27 that the 
addition of MTs increases the ATPase activity of the expressed construct of cytoplasmic dynein 
as expected.  Since cytoplasmic dynein interacts with MTs via a unique MTBD, compounds that 
bind to the MTBD could potentially interfere with cytoplasmic dynein latching onto MTs and 
being transported in the GR-GFP translocation assay. 
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Figure 27. Comparison of Basal and MT-Stimulated ATPase Activity of Cytoplasmic Dynein 
Red circles represented the amount of free inorganic phosphate detected with modified malachite reagents 
upon hydrolysis of ATP by basal cytoplasmic dynein as a function of absorbance at 630 nm.  Black diamonds 
represented the amount of free inorganic phosphate detected with modified malachite reagents upon hydrolysis of 
ATP by MT-stimulated cytoplasmic dynein as a function of absorbance at 630 nm. Data represented as mean values 
with SD from three independent measurements and fit to a linear curve. 
 
Results from the ATPase activity assays showed that only four of the compounds 
exhibited any significant concentration dependent effect on the ATPase activity of both basal and 
MT-stimulated activity of cytoplasmic dynein (Figure 28A,C).  Both enantiomers of 
apomorphine inhibited cytoplasmic dynein at similar IC50 values, whether in the basal or MT-
stimulated state (Table 2).  6-Nitroso-1,2-benzopyrone and Bay 11-7085 also inhibited 
cytoplasmic dynein but there was a more significant change in IC50 values between basal and 
MT-stimulated states.  Although there was no indication that any of the compounds significantly 
altered the interaction of cytoplasmic dynein’s MT-binding domain with the MTs, this type of 
comparison can be important in identifying compounds that interfere with the dynein-MT 
interaction in future screens.  The decreased IC50 value of 6-nitroso-1,2-benzopyrone in the MT-
stimulated state could indicate the targeting of nitric oxide or one of its oxidizing offspring on 
the sulfhydryls on tubulin heterodimers (Ikeda and Steiner, 1978) and subsequently destabilizing 
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the MTs as suggested by the decreased MT polymerization in Table 1, rather than binding to a 
defined active site.  The double sigmoidal behavior of 6-nitroso-1,2-benzopyrone also suggested 
its non specific binding to cytoplasmic dynein (Figure 28B,D).  
 
Figure 28. Cytoplasmic Dynein ATPase Inhibition Assay with LOPAC Collection 
A) Percent inhibition of ATPase activity of basal dynein with test compounds compared to DMSO control 
and sodium orthovanadate as a control.  B) Concentration-dependent inhibition of basal cytoplasmic dynein ATPase 
activities of 6-nitroso-1,2-benzopyrone, Bay 11-7805, and the enantiomers of apomorphine.  C) Percent inhibition of 
ATPase activity of MT-stimulated dynein with test compounds compared to DMSO control and sodium 
orthovanadate as a control.  D) Concentration-dependent inhibition of MT-stimulated cytoplasmic dynein ATPase 
activities of 6-nitroso-1,2-benzopyrone, Bay 11-7805, and the enantiomers of apomorphine.  Data represented as 
mean values with SD from eight independent measurements. 
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Table 2. Biochemical IC50
Compound 
 values of test agents against both basal and MT-stimulated cytoplasmic dynein. 
IC50
Basal 
 (µM) 
MT-Stimulated 
(R)-Apomorphine HCl hydrate 1.5 1.7 
(S)-Apomorphine HCl hydrate 1.5 1.3 
6-Nitroso-1,2-benzopyrone 1.8 0.7 
Bay 11-7085 4.6 8.9 
 
The MLSCN compounds at a concentration of 20 µM were then tested for effects on the 
ATPase activity of basal cytoplasmic dynein.  From the 69 compounds tested, it was encouraging 
to observe that 17 compounds exhibited a mean inhibition of ATPase activity by >50%.  
 
Figure 29. Cytoplasmic Dynein ATPase Inhibition Assay with MLSCN Collection 
Percent ATPase activity inhibition of test compounds against basal cytoplasmic dynein compared to an 
orthovanadate (OV) control.  Seventeen out of a total of 69 compounds exhibited competition >50% (chemical 
structures shown in Appendix A).  Data represented as mean values with SD from three independent measurements. 
3.2.2.5 Eliminating Non-Specific Motor Protein Inhibitors 
Finally, in order to rule out any compounds that might be general ATPase motor protein 
inhibitors, the compounds’ abilities to inhibit the ATPase activities of both kinesin and myosin 
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were tested, especially since the only known specific inhibitor of cytoplasmic dynein, purealin, is 
also a myosin activator.  As with previous results, vehicle tolerance experiments indicated that 
DMSO could be used in myosin ATPase assays at a content of up to 5% before any decrease in 
absorbance signal was observed (Figure 30).  Unfortunately, even after several exhaustive 
attempts to optimize buffers and reagents, measurement of kinesin ATPase activity was hindered 
by formation of a precipitate immediately after the addition of modified malachite reagents with 
any sample containing DMSO.  Detection of the ATPase activity of kinesin was conducted using 
the buffer and protein concentrations described in Funk et al. (2004), but also displayed 
precipitate formation immediately after addition of modified malachite reagents and therefore 
future assays may require the use reagents obtained from Cytoskeleton, Inc for this assay to be 
successful.  
 
Figure 30. DMSO Tolerance of Myosin ATPase Activity 
The ATPase activity of myosin was evaluated at different DMSO concentrations.  The maximum (max) 
signal represented the amount of free inorganic phosphate detected with modified malachite reagents upon 
hydrolysis of ATP by myosin as a function of absorbance at 630 nm.  The minimum (min) signal represented the 
amount of free phosphate detected with modified malachite reagents in the absence of ATP.  The blank signal 
represents the absorbance change of buffer and modified malachite reagents due to DMSO alone.  Data represented 
as mean values with SD from three independent measurements. 
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At the two concentrations the Sigma LOPAC members were examined, 10 µM and 50 
µM, only the apomorphines exhibited any significant inhibition of the ATPase activity of myosin 
(Figure 31A) with concentration-dependent behavior and IC50 values of 1.4 and 3.2 µM for the R 
and S enantiomers, respectively (Figure 31B).  The broad spectrum of targets apomorphine 
exhibited in our assays suggests that apomorphine would not be an attractive cytoplasmic dynein 
inhibitor despite being the most potent in our assays; i.e., these enantiomers were promiscuous 
compounds.  
 
Figure 31. Myosin ATPase Inhibition Assay with LOPAC Collection 
A) Percent inhibition of ATPase activity of myosin with test compounds compared to DMSO control and 
NEM as a control.  B) Concentration-dependent inhibition of myosin ATPase activity by the enantiomers of 
apomorphine. Data represented as mean values with SD from six independent measurements. 
 
Upon evaluation of the MLSCN collection against the ATPase activity of myosin, it was 
revealed that only two compounds out of 69 inhibited the ATPase activity of myosin >50%.  
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This was an encouraging observation suggesting that indeed compounds were specifically 
targeting the cytoplasmic dynein complex to inhibit GR-GFP translocation.  
 
Figure 32. Myosin ATPase Inhibition Assay with MLSCN Collection 
Percent ATPase activity inhibition of test compounds against myosin compared to an N-ethylmaleimide 
(NEM) control.  Only two out of a total of 69 compounds exhibited competition >50% (chemical structures shown 
in Appendix A).  Data represented as mean values with SD from three independent measurements. 
3.3 CONCLUSIONS 
Cell-based screening reliably revealed a number of small molecules from LOPAC and MLSCN 
collections that stalled the agonist-induced transport of GR from the cytoplasm to the nucleus.  
Since there are a number of potential reasons for interruption of this dynein-mediated transport, I 
sought to identify the target(s) of these molecules through a number of biochemical assays 
applicable to the translocation process.  The potential target(s) of these molecules were 
summarized in Table 3.  
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Table 3. Summary of the potential target(s) of molecules that inhibited GR translocation.    
Compound Dynein Microtubules Hsp70 Hsp90 GR Myosin 
4-Phenyl-3-furoxancarbonitrile       
Parthenolide       
(R)-Apomorphine HCl Hydrate       
(S)-Apomorphine HCl Hydrate       
6-Nitroso-1,2-benzopyrone       
Calcimycin       
GR-127935       
Bay 11-7085       
MLSCN#4  NA NA NA   
MLSCN#6  NA NA NA   
MLSCN#7  NA NA NA   
MLSCN#10  NA NA NA   
MLSCN#11  NA NA NA   
MLSCN#17  NA NA NA   
MLSCN#19  NA NA NA   
MLSCN#23  NA NA NA   
MLSCN#27  NA NA NA   
MLSCN#29  NA NA NA   
MLSCN#32  NA NA NA   
MLSCN#57  NA NA NA   
MLSCN#62  NA NA NA   
MLSCN#64  NA NA NA   
MLSCN#65  NA NA NA   
MLSCN#66  NA NA NA   
MLSCN#67  NA NA NA   
A () indicated that compounds targeted (≥50%) a particular component of the cytoplasmic 
dynein-cargo complex, while a () indicated that there was little (<50%) or no interaction of 
compound with target(s). 
 
From the seven LOPAC compounds tested, the apomorphine enantiomers exhibited the 
most potency towards the ATPase activities of cytoplasmic dynein and myosin, but also 
appeared to inhibit GR binding.  The pleiotropic property of these mirror image molecules, 
however, makes them unattractive for further study in this quest.  Parthenolide is a previously 
recognized MT stabilizer that most likely altered the tracks needed for dynein to transport GR-
GFP to the nuclei.  Based on the chemical structures of the remaining cell-based screening hits 
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from the LOPAC collection, it is likely that the compounds targeted reactive sulfhydryls of 
dynein and MTs, both contributing to inhibition of dynein-mediated transport.  The reliability of 
the LOPAC hits from the cell-based screen was further supplemented by the concentration 
dependent inhibition of activity determined from the biochemical assays with R2 values >0.9 for 
the fitted curves.  A number of compounds from the MLSCN collection were then tested using 
384-well plates.  Seventeen compounds were shown to have a mean ATPase activity inhibition 
>50% against cytoplasmic dynein.  Several of these compounds also targeted either GR or 
myosin.  Given the large standard deviation of the Hsp70 assay, further replicates are needed to 
reach any final conclusions regarding inhibition of ATPase activity.  Ideally, specific dynein-
mediated transport inhibitors would target dynein itself rather than one of the other important 
proteins associated with the transport process.  Although the hits from the cell-based screen of 
the 1280 LOPAC collection did not exhibit this desired profile, a number of compounds from the 
MLSCN screen appear to have greater specificity towards dynein.  Future experiments involving 
the ATPase activity inhibition assay of Hsp90 and the MT perturbation screen will help 
categorize how compounds inhibit GR translocation.  Concentration-dependent assays with the 
compounds will also determine their binding strength and specificity.  Regardless of 
identification of dynein modulators from the tested libraries, these assays demonstrated the 
ability to examine cell permeable inhibitors of GR translocation followed by an attempt to 
identify the target(s) of these molecules through biochemical screening.  We envision that further 
screening of additional compound libraries for inhibition of cell-based cytoplasmic dynein 
transport will reveal specific cytoplasmic dynein and/or Hsp inhibitors.  We also believe this 
route of identifying inhibitors via a cell based assay followed by target validation is an 
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improvement over conventional biochemical screening that suffers when “hits” eventually are 
cell impermeable and/or severely cytotoxic.   
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4.0  DEVELOPMENT OF BIOSENSOR APPLICATIONS TO EVALUATE 
MICROTUBULE PERTURBING AGENTS  
4.1 INTRODUCTION 
Results published in Daghestani, H.N.; Fernig, D.G.; Day, B.W. Evaluation of biosensor surfaces 
for the detection of microtubule perturbation. Biosens. Bioelecron., 2009, 25, 136-141. 
  
Biosensors have many applications, providing data to help explain biological questions ranging 
from macromolecular interactions (Lillis et al., 2006) to the binding of small molecules to 
surfaces and immobilized large molecules (Karlsson, 2004; Boozer et al., 2006).  There are 
several types of instruments available that use different detection methods, each possessing their 
own advantages and disadvantages.  Although DPI provides more detailed information of 
samples on the sensing surface, its current flow-through configuration consumes a much larger 
amount of sample in comparison with RM’s small volume (microliter) cuvette.  The RM cuvettes 
are also re-usable for multiple experiments.  The ability to grow MTs on surfaces is also an 
important step in the development of more robust high throughput (e.g., microtiter plate-based or 
microarray) assays to monitor MT polymerization in the presence of various de-/stabilizing 
agents as discussed in the previous chapter.  Here, a novel method is discussed to polymerize 
MTs on biosensor surfaces and demonstrate the ability to distinguish the interaction of stabilizers 
from destabilizers on MTs using a combination of RM and DPI, a major advance on previous 
 91 
work where only the binding of MT inhibitors to tubulin immobilized onto SPR surfaces has 
been reported (Aoyama et al., 2007).  
4.2 RESULTS & DISCUSSION 
4.2.1 Microtubule Polymerization on Biosensor Surfaces 
Initial attempts to immobilize tubulin directly onto non-functionalized surfaces were 
unsuccessful, with changes in thickness of the layer determined by DPI measurements rarely 
exceeding 2 nm, rather than the expected 4 nm width or 8 nm height of a tubulin heterodimer, 
most likely due to denaturation of the protein upon contact with the somewhat hydrophobic 
biosensor surfaces (Andrade and Hlady, 1986).  After trials with various functionalized surfaces, 
biotinylated surfaces appeared to provide the best environment for a streptavidin layer followed 
by subsequent biotinylated tubulin and MT layers.   
A key feature of tubulin polymerization is its temperature dependence (Hamel, 2003), 
with the ordered assembly of mammalian tubulin occurring optimally at 37 °C, while cold 
temperatures tend to destabilize MTs.  Turbidimetry experiments, most commonly used to 
measure MT polymerization and the influence of test agents on tubulin/MT dynamics (Hamel, 
2003; Hall and Minton, 2005), are typically started at 0 °C to 4 °C and the change in absorbance 
is recorded while increasing the temperature to ≥ 26 °C (typically 30 °C or 37 °C) and 
subsequently dropping the temperature back to 4 °C to determine the stability of the MTs.  The 
ability of biotinylated tubulin to successfully polymerize was assessed by performing a standard 
turbidity assay.  Tubulin conjugated with a maleimide-based biotin was inactive, most likely 
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because microtubule polymerization is very sensitive to blocking of the many free sulfhydryl 
groups on α and β tubulin (Ikeda and Steiner, 1978).  Although biotin conjugation to tubulin via 
amine-reactive agents renders far more labels on tubulin than thiol-reactive groups, biotinylated 
tubulin was still active.  Polymer formation required more time to occur when only biotinylated 
tubulin was used compared to a 1:1 mixture of tubulin:biotinylated-tubulin and even more so 
than tubulin alone (Figure 33).   
 
 
Figure 33. Functionality of Biotinylated Tubulin 
 Microtubule polymerization was monitored by the change in turbidity at 340 nm when 10 µM tubulin 
supplemented with GTP was warmed from 4 °C to 37 °C.  The absorbance of 1 M MSG buffer did not change due 
to the change in temperature, while the bovine brain tubulin-containing sample increased in absorbance within 5 min 
of warming.  A 1:1 mixture of tubulin:biotinylated tubulin formed the same amount of polymer as the tubulin 
sample but required a longer time to fully polymerize.  Biotinylated tubulin was also capable of forming polymer but 
at a much slower rate than the former samples, suggesting that biotinylated tubulin was active for further studies.   
 
 
Streptavidin was deposited on a biotinylated DPI Amine AnaChip™ to form a layer with 
a mass of 3.34 ng/mm2, thickness of 5.94 nm and a density of 0.56 g/cm3, consistent with 
previously obtained values and the dimensions of streptavidin derived from X-ray 
crystallography (Swann et al., 2003).  The addition of biotinylated tubulin caused mass and 
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thickness to increase to 4.12 ng/mm2 and 7.18 nm, respectively, accompanied by an increase in 
density to 0.57(5) g/cm3, which indicates binding of biotinylated tubulin to the streptavidin 
surface (Figure 34).   
 
Figure 34. Resolved Mass, Thickness, and Density of Tubulin Assembly as Assessed with DPI 
(A) The increase in mass when streptavidin, biotinylated-tubulin, and tubulin were added indicated specific 
binding to each of the underlying layers.  (B) The increase in thickness with decreasing density after the addition of 
tubulin to biotinylated tubulin suggested the formation of MTs on the biosensor surface [adapted from Daghestani et 
al., 2009 with permission from publisher]. 
 
The increase in thickness above the streptavidin layer was only 1.24 nm, rather than the 
size of a tubulin heterodimer (~8 nm), accompanied by a slight increase of 0.01 g/cm3 in the 
density.  The small increase in mass (molar ratio of biotinylated tubulin to streptavidin of 1:7) 
suggested that the layer of tubulin formed might not be optically homogeneous, since it 
corresponds to a surface coverage by biotinylated tubulin of the order of 12%, compared to 35% 
coverage for streptavidin (Swann et al., 2004).  The initial binding of biotinylated-tubulin to the 
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streptavidin was rapid, however, which suggested the association of biotinylated-tubulin to 
streptavidin to be specific, while the increase in density indicated that other processes occurred 
simultaneously.  Thus, an alternative but not mutually exclusive explanation is that, since tubulin 
has many exposed lysine residues, biotin may occupy multiple positions on the heterodimer and 
at various locations throughout, resulting in a number of different orientations of biotinylated-
tubulin bound to streptavidin. For example, heterodimers that lie on their sides might fill any 
gaps between streptavidin molecules, accounting for the small thickness and density increase.  
Other orientations are likely to either promote or block subsequent binding of heterodimers to the 
surface depending on its surrounding environment.  Nonetheless, the immobilized biotinylated-
tubulin was sufficient to provide a starting point for MT growth.  Any unbound biotinylated-
tubulin was then washed away when the injection was complete and flow returned to running 
buffer.  The subsequent introduction of tubulin in sample buffer caused a significant increase in 
mass and thickness reaching up to 22.85 nm with a continuous decrease in density to 0.40 g/cm3.  
The increase in thickness provided evidence that MTs were growing vertically on the surface, 
while the decrease in density is in accord with the formation of hollow MTs that are quite sparse, 
rather than continuous layering of tubulin dimers onto the surface.  The first 10 min of the 
process may represent the initial nucleation and elongation process of protofilaments at a rate of 
0.236 nm/min before an inflection point, where the extended protofilaments is believed to join 
together laterally to form the microtubule and the growth process accelerated to 0.436 nm/min 
(Figure 35).  
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Figure 35. Schematic Representation of the Microtubule Polymerization Process on Biosensor Surfaces 
(A) Schematic representation of the formation of a uniform streptavidin layer on a biotin chip followed by 
the growth of tubulin protofilaments on biotinylated tubulin.  (B) As protofilaments continue to grow in length, they 
join laterally to form MTs [adapted from Daghestani et al., 2009 with permission from publisher]. 
 
Microtubule growth was halted in instances where the tubulin flow was decreased or stopped for 
an incubation, which reflects the need for mixing to take place near the surface.  In a flow 
system, which is limited by the properties of laminar flow, mixing can only occur by flowing the 
sample relatively rapidly.  The DPI chips were cleaned for re-use with various surfactant 
cleaners, sodium dodecyl sulfate, ethanol/acetone, etc., all while sonicating the chips followed by 
rinsing with deionized water. When chips were placed back into the instrument, however, the 
fringes had very low contrast and baseline signal was not stable enough to perform an 
experiment.  Other harsher methods that etch the surface could be used, but will likely require 
the reintroduction of amine functional groups onto the chip surface before use.  
Once MT polymerization was established on such surfaces using data from DPI, the 
assembly of MTs was evaluated using the RM cuvette system in an effort to establish a technique 
that conserves sample, is more user-friendly and applicable to larger sampling sets.  The addition 
of streptavidin in 10 mM phosphate buffer, pH 7.7, at 37 °C to a biotinylated RM cuvette caused 
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a typical increase in response to ~2000 arcseconds over approximately 15 min and excess 
streptavidin was removed by a phosphate buffer wash (Figure 36).  The phosphate buffer was 
then replaced by 1 M MSG buffer, which caused a large bulk shift, followed by the addition of 
biotinylated tubulin until the response reached a plateau.  The addition of soluble tubulin to the 
biotinylated-tubulin-streptavidin RM surface caused a bulk shift over the first 5 s, followed by a 
continuous increase in response, corresponding to an increase in mass at the surface.  In other 
attempts to assemble MTs on the surface, the addition of GTP after tubulin caused the increase in 
response to halt, possibly due to the polymerization of tubulin in solution rather than on the 
surface.  It is thought that the presence of a high concentration of GTP near the surface of the 
cuvette and the biotinylated tubulin allows for the tubulin to diffuse towards and bind to the 
surface.  
 
Figure 36. Microtubule Assembly Process as Assessed with RM 
The increase in response due to the addition of streptavidin and subsequently biotinylated tubulin without 
the decrease in signal upon buffer washes indicated their specific binding events.  The addition of tubulin to the 
biotinylated tubulin layer containing GTP demonstrated continuous growth periods and was repeatable over several 
buffer wash cycles without any significant loss of underlying biotinylated tubulin layer [adapted from Daghestani et 
al., 2009 with permission from publisher]. 
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The non-linear behavior of signal increase and occasional “bursts” of sudden increase in 
response in Figure 37 suggested periods of MT rescue and catastrophe events.  The return of 
response back to baseline after a buffer wash indicated the removal of the polymerized tubulin 
layer rather than the underlying biotinylated tubulin layer.  Tubulin polymerization on such 
surfaces was reproducible over several (~20) cycles, but activity was lost once the surface was 
left at room temperature or at 4 °C overnight. 
 
Figure 37. Microtubule Polymerization on a RM Biosensor 
Binding profile of tubulin to a biotinylated tubulin surface in 1 M MSG buffer, pH 6.6, with GTP at 37 °C 
using the RM biosensor.  The response continuously increased until a buffer wash was performed and the process 
repeated.  The increase in response was non-linear and exhibited “bursts” that suggest rescue and catastrophe events 
[adapted from Daghestani et al., 2009 with permission from publisher]. 
 
The ability of preformed MTs to bind to a biotinylated tubulin surface was also assessed.  
The binding of preformed MTs, however, was non-specific as indicated by the step response 
upon sample addition and subsequent wash.  The large change in response was primarily due to a 
bulk shift of the MTs and further response increase was not observed in instances where 
preformed MTs were added (Figure 38), suggesting that MTs simply lay horizontally on the 
surface rather than the suggested model in Figure 35B.  The buffer wash following preformed 
MT deposition also appeared to remove some of the biotinylated tubulin layer.  
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Figure 38. Binding of Preformed Microtubules to a Biotinylated Tubulin Surface as Assessed with RM 
The addition of preformed microtubules to a biotinylated tubulin surface and subsequent buffer wash 
caused a step-like response suggesting non-specific binding to the surface.  The buffer wash also caused a loss in 
biotinylated tubulin layer.  
4.2.2 Temperature Dependent Microtubule Polymerization using Biosensors 
The temperature dependence of tubulin polymerization was evaluated on the RM surface to 
further demonstrate the functionality of tubulin on biosensor surfaces.  Due to fogging of the 
optical system, the lowest temperature achievable on the system was 15 °C, which is still an 
acceptable starting point for soluble (unpolymerized) tubulin, since normal polymerization does 
not take place at temperatures below 15 °C (Olmsted and Borisy, 1973).  Since refractive index 
is also temperature-dependent (Grassi and Georgiadis, 1999), the response from a separate 
channel (reference channel) containing only sample buffer was subtracted from the sample 
channel to obtain the absolute change in response upon temperature change.  The binding of 
tubulin to the surface at 15 °C was a slow process (Figure 39) and reached a plateau with a lower 
response rather than exhibiting the continuously increasing response observed at 37 °C in Figure 
37.  The lower response of tubulin binding at 15 °C was most likely due to the lower affinity of 
 99 
heterodimer association at such temperatures.  Once the temperature was increased to 37 °C, the 
absolute change in response increased, suggesting increased binding to the surface.  It is worth 
mentioning that the change in response in Figure 39 does not correspond to the observations 
from Figure 37, most likely due to the preference and shift in dynamics of tubulin to polymerize 
in solution rather than on the surface with such conditions.  This is also suggested by the 
observation that addition of GTP after the addition of tubulin did not show a large increase in 
response as in Figure 37.  MT polymerization in solution most likely occurs in both situations 
due to the constant collisions of tubulin heterodimers and protofilaments with each other.  The 
difference in the amount of solution polymerization is speculated to be a result of Fick’s law of 
diffusion; at lower temperatures, mass transfer of the macromolecules to the surface is decreased 
due to the increased viscosity of the solution (Seeton, 2006).  As a result, there is less 
protofilament seeding occurring near the surface at 15 °C and polymerization in solution 
becomes more favorable once temperature is increased.  When tubulin is introduced at 37 °C, 
mass transfer of the tubulin to the surface is greater and the current temperature allows for 
binding to biotinylated tubulin and further MT polymerization onto the surface.  Previous SPR 
studies have also indicated that binding association constants of antigen-antibody interactions are 
greater when temperature is increased (Zeder-Lutz et al., 1997), supporting the argument that 
increased mass transfer at higher temperatures affects the rate of interactions at a surface.  
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Figure 39. Temperature Dependent Microtubule Polymerization assessed with RM 
Temperature dependence of tubulin binding to biotinylated tubulin using the RM biosensor.  “Sample 
Channel” represents the observed response of the instrument upon the addition of tubulin to a biotinylated tubulin 
surface at 15 °C followed by an increase in temperature to 37 °C, where the dotted line indicates the start of 
temperature change.  “Reference Channel” represents the change in response due to the change in temperature.  
“Difference” represents the subtraction of “Reference Channel” from the “Sample Channel” to give the absolute 
change in response due to the change in temperature [adapted from Daghestani et al., 2009 with permission from 
publisher]. 
 
In an effort to evaluate the effect of stabilizers and destabilizers on the binding of tubulin 
to biotinylated-tubulin surfaces, either paclitaxel or colchicine, respectively, were introduced to 
the mixture.  When paclitaxel was added to the cuvette before the addition of tubulin, a similar 
binding profile was observed, even after the temperature change  (Figure 40).  The binding 
response was also generally more stable to subsequent decreases in absolute response observed 
after a few minutes with tubulin alone, which most likely represent events of MT disassembly.  
Colchicine had a delayed inhibition effect when added before tubulin, in all likelihood due to its 
known slow association rate with tubulin (Banerjee et al., 1997), especially since it completely 
inhibited binding when pre-incubated with tubulin on ice for 15 min prior to the addition of the 
tubulin to the cuvette.  This provided further evidence that microtubules bound to the surface 
were functional and exhibited similar characteristics as those in solution.  
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Figure 40. Effect of Microtubulue Perturbing Agents on the Temperature-Dependent Polymerization as 
Assessed with RM 
The absolute change in response starting from the time of temperature change from 15 to 37 °C is shown.  
Paclitaxel addition gave a similar response to tubulin with GTP, but the MTs formed remained more stable from 
disassembly afterwards. Colchicine caused a decrease in the response after an initial increase in response, but 
completely inhibited binding when it was pre-incubated with tubulin [adapted from Daghestani et al., 2009 with 
permission from publisher]. 
4.2.3 Comparison of Microtubule-Perturbing Agents Using RM Biosensors 
The binding profile of microtubule polymerization generally did not fit well to mono- or bi-
phasic binding profiles upon analysis with FASTfit Software (NeoSensors, Ltd., UK).  This is 
not necessarily surprising given the complexity of MT polymerization (Hall and Minton, 2005), 
which involves many processes, such as GTP binding and hydrolysis, as well as constant 
assembly and disassembly events (Jordan and Wilson, 2004).  The most consistent parameter, 
however, that described interactions of tubulin with various agents from biosensor experiments 
appeared to be the slopes of initial rates of assembly: the change in response during the first 15 s 
after tubulin is added to a cuvette pre-warmed to 37 °C with buffer containing GTP (allowing for 
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a 5 s mixing time during the bulk shift).  These values appear to provide a means to evaluate the 
polymerization process in the presence of various de-/stabilizer agents.  When paclitaxel and 
epothilone B, both MT stabilizers, were introduced to the system, the slopes of initial rates (mean 
± SD, n=3) were significantly higher at 1.50 ± 0.27 arcseconds/s and 1.04 ± 0.13 arcseconds/s, 
respectively, compared to 0.37 ± 0.11 arcseconds/s for tubulin containing GTP only (Figure 41).  
This is expected given that tubulin in the presence of paclitaxel polymerizes at a faster rate than 
in the presence of epothilone B (Gertsch et al., 2009).  In the presence of MT destabilizers such 
as colchicine and dolastatin 10, the slopes of initial rates were lower than in their absence at 0.05 
± 0.01 arcseconds/s and 0.27 ± 0.08 arcseconds/s, respectively.  Thus, the present approach 
provides a means for screening, differentiating compounds acting as stabilizers from those that 
are destabilizers based on the slopes of initial rates. 
 
Figure 41. Comparison of the Slopes of Initial Rates of Microtubule Assembly with Various Microtubule-
Perturbing Agents 
Paclitaxel and epothilone B, both MT stabilizers, exhibited greater slopes of initial rates in comparison with 
the DMSO control.  MT destabilizers, colchicine and dolastatin, gave lower values than the control.  Values are 
reported as a mean with n=3 and the error bars representing the standard deviation.  The pair-wise P values in 
comparison with the tubulin control were 0.035, 0.005, 0.033, and 0.838 for paclitaxel, epothilone B, colchicine, and 
dolastatin 10, respectively [adapted from Daghestani et al., 2009 with permission from publisher].  
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4.3 CONCLUSIONS 
The ability to grow MTs vertically on surfaces is a novel approach and vast improvement over 
other techniques that directly deposit soluble tubulin onto SPR surfaces to evaluate agent 
binding.  This is because the functionality and dynamics of MT polymerization can be assessed 
in the presence of compounds rather than merely agent binding.  In addition, the deposition of 
tubulin directly onto a surface may likely block agent binding access to a large surface area of 
the protein.  Resolved mass, thickness, and density measurements from DPI indicated the growth 
of protofilaments on a biotinylated-tubulin/streptavidin surface, followed by the polymerization 
of microtubules.  MT polymerization on surfaces was then evaluated on RM biosensors in order 
to increase throughput and decrease sample consumption.  The temperature and perturbing agent 
–dependence of MT polymerization evaluated by RM behaved similarly to turbidity experiments.  
MT stabilizing agents were clearly distinguishable from MT destabilizing agents compared to a 
DMSO control using the slopes of initial rates.  These results are encouraging for future 
screening of MT perturbing compounds.  Although RM biosensors can only accommodate two 
simultaneous channels, RWG biosensors offer a very similar detection capability and sensitivity 
but are capable of implementation into 96-, 384-, and 1536-well plates for higher throughput and 
even less sample consumption.  
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5.0  BIOPHYSICAL CHARACTERIZATION OF CYTOPLASMIC DYNEIN 
5.1 INTRODUCTION 
The large size of cytoplasmic dynein renders structural characterization immensely difficult by 
conventional NMR and X-ray crystallography.  A number of researchers have attempted to 
characterize the structure of cytoplasmic dynein by negative stain and cryo- electron microscopy, 
but have not been able to break the 25Å resolution barrier (Samso and Koonce, 2004).  Many of 
these structures have provided an immense amount of information regarding the structural 
changes that take place upon ATP binding and hydrolysis followed by the release of ADP 
(Burgess et al., 2003).  The crystal structure of the MTBD of cytoplasmic dynein explains the 
binding mechanism to MTs (Carter et al., 2008).  Biophysical studies have also provided insights 
into the stepping size and forces as cytoplasmic dynein translocates in a retrograde manner along 
MTs (Mallik et al., 2004).  Computational models have also been proposed to simulate the 
atomic structure of cytoplasmic dynein’s motor domain (Mocz and Gibbons, 2001; Serihojis et 
al., 2006), but have not been correlated with experimental methods.  Here, a computational 
model of mammalian cytoplasmic dynein was generated and results were compared with 
experimental data obtained from several biophysical techniques as a method to discern details of 
the cytoplasmic dynein motor domain and provide a stepping-stone to propose a more accurate 
representation of the protein.  
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5.2 RESULTS & DISCUSSION 
5.2.1 Computational Modeling of Cytoplasmic Dynein Heavy Chain 1 Motor Domain 
5.2.1.1 Secondary Structure Prediction 
There are many computational programs available that can provide insight into the secondary 
and tertiary structures of proteins based on the amino acid sequence by comparison with known 
crystallographic and NMR structures deposited in the protein data bank (PDB).  Unfortunately, 
the present form of the PDB does not contain structural data for proteins of similar large size and 
sequence homology to cytoplasmic dynein heavy chain 1.  Computational programs are also 
often restricted by the input size of amino acid sequences, as was the case when searching for 
programs that could be used for secondary structure and disulfide bond prediction of cytoplasmic 
dynein.  NetSurfP ver. 1.1 (Petersen et al., 2009) was the one of very few available programs 
found to be capable of handling the long sequence of cytoplasmic dynein heavy chain 1 for 
secondary structure prediction.  This program employs a neural network algorithm to predict the 
secondary structure of a protein from an input amino acid sequence.  The output is a probability 
score, ranging from 0 to 1, given for each residue to be in an alpha-helical, beta sheet, or random 
coil conformation.  Typically probability values are plotted as a function of residue number, but 
as observed in Figure 42, the plot for cytoplasmic dynein heavy chain 1 was quite complex and 
difficult to discern.  The data was simplified by plotting the probabilities of the secondary 
structures in a histogram (Figure 43), where it became more evident that the predicted secondary 
structure of cytoplasmic dynein heavy chain 1 motor domain was heavily alpha-helical, in 
accordance with previous models proposed by Mocz and Gibbons (2001) and Serihojis et al. 
(2006).  Partitioning the sequence into smaller, more manageable, sequences with overlapping 
 106 
portions proved to be unfruitful since secondary structure prediction of several of the 
overlapping regions did not match with each other. 
 
Figure 42. Secondary Structure Prediction of Cytoplasmic Dynein Motor Domain 
Probabilities for formation of secondary structures: alpha helix (red), beta sheet (blue), or random coil 
(grey) as a function of residue number of rat cytoplasmic dynein heavy chain 1.  
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Figure 43. Histogram of Secondary Structure Probabilities for Cytoplasmic Dynein Motor Domain 
Range of probabilities for formation of secondary structures: alpha helix (red), beta sheet (blue), or random 
coil (grey) of rat cytoplasmic dynein heavy chain 1.  
 
Additionally, a prediction of dihedral (Φ,Ψ) angles from the protein sequence by guided-
learning (Faraggi et al., 2008) provided an alternative means to predict secondary structure 
through the use of a Ramachandran plot.  The sequence of rat cytoplasmic dynein was submitted 
to Real-SPINE 3.0 (Faraggi et al., 2008) and the program output was in the form of predicted 
dihedral angles for each residue.  As evident from Figure 44, there was a large cluster of residues 
predicted to lie in the lower left quadrant of the Ramachandran plot, an indication of right-
handed alpha-helices (Oldfield and Hubbard, 2004).  Unexpectedly, a large number of residues 
resided in the upper left quadrant, a prediction of beta sheet structure, while very few residues 
were in the upper right quadrant that provides a prediction of random coils (Oldfield and 
Hubbard, 2004).  The large size of the sequence hinders the ability to evaluate it with multiple 
programs. making it difficult to reach any conclusive results without comparison with other 
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programs. Yet, these results hint at the predominant alpha-helical nature of cytoplasmic dynein 
heavy chain 1.   
 
Figure 44. Ramachandran Plot of Predicted Dihedral Angles of Cytoplasmic Dynein Motor Domain 
Predicted dihedral angles are plotted to show the steric conformation of residues.  Conformations in the 
lower left quadrant represent alpha helices. Conformations in the upper left quadrant represent beta sheets, while 
conformations in the upper right quadrant represent random coils.  
 
In addition to secondary structure prediction, disulfide connectivity prediction can be 
instrumental in assisting with modeling and characterization of the structure of a given protein.  
Similar to most computational programs, many of the programs available for disulfide bond 
prediction are incompatible with the large size of cytoplasmic dynein.  The program 
DISULFIND (Ceroni et al., 2006), which relies on predicting disulfide connectivity from a 
sequence using a trained neural network,  was found to be capable of analyzing the 380 kDa 
sequence of rat cytoplasmic dynein heavy chain 1.  The results from DISULFIND analysis 
indicated, however and with high statistical scoring, that disulfide bonds do not exist in the 
structure.  It is unclear at this point if these results are reliable given the large number (41) of 
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cysteines present in the sequence.  It is, however, possible that disulfide bonds do not exist in the 
structure given the fact that cytoplasmic dynein’s environment in the cytoplasm is reducing and 
is therefore not conducive to disulfide bond formation (Fahey et al., 1977).  This is also 
supported by the fact that MTs, which are also in the cytoplasm, are inhibited in the presence of 
oxidizing agents (Huber et al., 2008).  
5.2.1.2 Three Dimensional Modeling of Cytoplasmic Dynein Motor Domain 
Another avenue explored was 3D structural prediction of the motor domain of cytoplasmic 
dynein using comparative/homology modeling.  Since cytoplasmic dynein motor domain is a 
hexameric AAA protein, previous models of the structure have been proposed based on the 
shared homology of known AAA protein structures (Mocz and Gibbons, 2001; Serihojis et al., 
2006).  There is, however, very little correlation of these results with experimental data -- the 
previously reported structures were primarily fit into the electron density maps obtained by 
negative stain electron microscopy (Samso and Koonce, 2004).  Here, a computational model of 
rat cytoplasmic dynein heavy chain 1 motor domain was generated using MODELLER v9.8 
(Eswar et al., 2006).  Initial attempts to generate a model were unsuccessful (Figure 45) with 
many residues lacking coordinate specification due to the mismatch in number of amino acids 
between the input sequence and the PDB files of the previously proposed models.   
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Figure 45. Surface Representation of Comparative/Homology Structural Models of Cytoplasmic Dynein 
Motor Domain 
Residues Gly1286-Glu4644 of rat cytoplasmic dynein heavy chain 1 were applied to MODELLER v.9.8 to 
generate models of the motor domain based on comparative homology modeling using A) PDB 1HN5 (Mocz and 
Gibbons, 2001) and B) 2GF8 (Serohijos et al., 2006) as a templates.   
 
A sequence homology alignment was conducted using Clustal W (Larkin et al., 2007) to 
identify and remove the mismatched amino acids from the input sequence.  Another model was 
generated using the truncated sequence with the PDB files 2GF8 (Serohijos et al., 2006) and 
1HN5 (Mocz and Gibbons, 2001) as the templates and the model with the lowest DOPE score 
was selected after five reiterated models were generated (Figure 46).  Surface volume rendering 
of this model indicated the presence of 15 surface-exposed cysteines.  
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Figure 46. Surface Representation of a Modified Comparative Homology Structural Model of 
Cytoplasmic Dynein Motor Domain 
Residues from rat cytoplasmic dynein heavy chain 1 that did not align with residues from PDB coordinates 
in 1HN5 and 2GF8 were deleted and the modified sequence was applied to MODELLER v.9.8 to produce a 
modified structural model of the motor domain.  Surface-accessible cysteine residues were highlighted in red.   
5.2.2 Cysteine Mapping 
In order to evaluate the computational model of cytoplasmic dynein motor domain produced 
(vide supra) and to validate the prediction of surface accessible cysteine residues, the number of 
reactive cysteines was investigated experimentally.  The motor domain of cytoplasmic dynein 
was labeled with a maleimide-based fluorescent dye under both native and denaturing 
conditions.  The fluorescence was measured as a function of protein concentration under both 
native and denaturing conditions (Figure 47).  By calibrating thiol concentration using 
glutathione, the number of reactive cysteines was initially determined for BSA to validate the 
method.  From the slope, it was determined that the ratio of cysteines compared to glutathione 
was 0.32.  Even though there is one surface-accessible cysteine in BSA, its reactivity has been 
reported to be relatively weak at neutral pH values, and in fact titrates with Ellman's reagent 
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[5,5'-dithiobis-(2-nitrobenzoic acid) or DTNB] at ~0.3-times the level of low molecular weight 
thiol-containing compounds (Svenson and Carlsson, 1975), suggesting that the reactivity of TG1 
was similar to the commonly used Ellman’s reagent.  The number of surface-accessible reactive 
cysteines of the 380 kDa cytoplasmic dynein heavy chain 1 protein in bulk solution was 
calculated to be 6, while under denaturing conditions (SDS) 15 additional reactive cysteines were 
revealed.   
 
Figure 47. Quantitation of Reactive Cysteines by Fluorescence Spectroscopy 
The amount of cysteines is determined from the slopes of concentration-dependent fluorescence of protein-
TG1 adducts for A) BSA and B) cytoplasmic dynein heavy chain 1 under both native and denaturing conditions.  
Error bars represent SD from three independent experiments.  
 
Although cytoplasmic dynein is not expected to possess disulfide bonds due to the 
inherent reducing environment of the cytoplasm (Fahey et al., 1977), bulk fluorescence results 
suggested the presence of 10 disulfide bonds (i.e., 
 
41 − 21
2
=10).  Reduction of protein disulfides 
before fluorescent labeling would have vindicated these findings, but TG1 interacted with all of 
the various reductants used (DTT, 2-mercaptoethanol, TCEP) as expected (Tyagarajan et al., 
2003), producing high fluorescence values independent of concentration (Figure 48).  Given that 
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sufficient amounts of protein concentration needed for experiments was difficult to express and 
purify, samples treated with reductants were not dialyzed in order to maintain enough sample for 
fluorescence analysis.  Alternatively, excess reductant may be dialyzed in a denaturing and 
deoxygenated buffer before labeling cysteines as described by Hedin et al. (2002).  
 
Figure 48. Time Dependence of GSH-TG1 Fluorescence Signal 
A) Variation of GSH concentration was used to calibrate reactive cysteines while time dependence 
indicated optimal time of 60 min incubation for fluorescence readings.  B) The addition of TCEP, independent of 
time or concentration, hindered fluorescence measurements.  
 
In order to verify the fluorescence spectroscopy results and to identify labeled cysteines, 
MS analysis of labeled proteins was performed.  Because of the large size of the protein and the 
complexity of the generated peptides generated, CNBr was initially selected as the method to 
digest cytoplasmic dynein, cleaving peptides only at methionine residues (Gross and Witkop, 
1962).  Upon analysis of the base peak chromatogram of the eluted peptides (Figure 49) a large 
number of ions were detected for a given time point  (Figure 50) even when a long elution 
gradient was applied.   
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Figure 49. Base Peak Chromatogram of CNBr Digests of Cytoplasmic Dynein from LC-ESI-TOF-MS with 
Positive Ion Detection 
A) CNBr digests of cytoplasmic dynein control.  B) CNBr digests of cytoplasmic dynein reacted with TG1.   
 
Figure 50. Positive Ion Mass Spectra of Cytoplasmic Dynein CNBr Digests from LC-ESI-TOF-MS Analysis 
A) Raw MS spectrum from the 11.8-12.1 min region of the base peak chromatogram showing the many 
ions detected.  B) The reconstructed spectrum shows many multiply charged ions detected.  
 
Upon reconstruction (a.k.a. deconvolution) of the spectrum (Figure 51), a monoisotopic 
mass list was generated using the SUM PEAK algorithm with multiply charged peptides ranging 
from 1182.5 – 63,431 Da in size.  The resolution of the TOF-MS instrument used did not, 
however, allow for clear correlation of detected peptide masses with those with in situ peptide 
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mass values, as many of the detected masses differed from potential values by several tens or 
even hundreds of Daltons.  
Although there was somewhat improved peptide separation when a nano-LC system was 
used (Figure 51), the complexity of samples still provided a very high number of ions detected 
by 12 Tesla FTMS after ESI, and many of the reconstructed spectra were overlapping (Figure 
52).  In addition to the complexity of the sample itself and the uncertainty of formation of serine 
or homoserine lactone with CNBr digestion (Gross and Witkop, 1961), the CNBr/formic acid 
mixture used for digestion can also introduce several types of variable modifications to peptides, 
including amide formylation and esterification of carboxyl groups (Goodlett et al., 1990), in 
addition to the potential missed cleavages that can take place (Lubec and Afjehi-Sadat, 2007).   
 
Figure 51. Base Peak Chromatogram of CNBr Digests of Cytoplasmic Dynein from nanoLC-ESI-FTMS with 
Positive Ion Detection 
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Figure 52. Mass Spectra of Cytoplasmic Dynein CNBr Digests from ESI-FTMS 
A) Raw positive ion MS spectrum from the base peak chromatogram showing the many ions detected.  B) 
The reconstructed spectrum shows overlapping multiply charged ions.  
 
 These results all hinted at the necessity for more detailed sequence information by 
tandem MS and perhaps peptide cleavage with reagents that cause less modifications and 
chemical interference as compared to CNBr.  TG1-labeled rat dynein heavy chain 1 motor 
domain was therefore electrophoresed in an SDS-PAGE system and the purified protein was 
digested in-gel with trypsin.  The peptides extracted from the gel plug were analyzed by nanoLC-
ESI-LIT-Orbitrap-MS and -MS/MS with positive ion detection.  Base peak chromatograms 
indicated a large amount of ions for both labeled and unlabeled samples (Figure 53).  The 
combined MS and MS/MS analyses identified a large amount of sequence information (shown in 
Appendix B) of both unlabeled and labeled protein with sequence coverages of 56.53% and 
61.59%, respectively, compared to the sequence coverage of ~4% with the FTMS.   
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Figure 53. Base Peak Chromatogram of CNBr Digests of Cytoplasmic Dynein from nanoLC-ESI-LIT-
Orbitrap with Positive Ion Detection 
A) In-gel trypsin digests of cytoplasmic dynein control.  B) In-gel trypsin digests of cytoplasmic dynein 
reacted with TG1.   
 
Upon further analysis of the identified peptides, seventeen total cysteines were detected 
on peptides, thirteen of which were detected with increased masses.  Initial modification searches 
using the ∆ mass of the expected TG1 adduct (379.1 Da) (Figure 54) resulted in identification of 
only a few labeled peptides, even though several other cysteines appeared to be modified.  Many 
of the modified peptides had ∆m/z values of 365, 383, or 397 Da rather than the parent adduct 
(shown in Appendix C) attributed to the modifications depicted in Figure 55 (Sharov et al., 
2006).  Although the size and fragmentation patterns of the TG1 adduct may encumber MS 
analysis, TG1 was selected for its common use to compare the results obtained by fluorescence 
measurements with MS analysis.  The labeled cysteines identified were compared with the 
predicted surface accessible residues in Table 4.  There were five cysteines that matched 
experimental and computational results.  The remaining eight cysteines identified experimentally 
may have been inadvertently labeled if excess TG1 was present during the denaturation step 
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before loading onto the electrophoresis gel, even though care was taken to remove label with 
centrifugal filtration units.  Since sequence coverage was not complete, there may be more 
labeled peptides detected, which could be in agreement with computational predictions.  
Additionally, given that the computational model of cytoplasmic dynein motor domain was 
generated from an incomplete sequence in comparison with other computational models, rather 
than experimentally determined structures with similar size and sequence homology, mismatch 
in surface-accessible cysteines may be due to errors in the model itself.      
 
Figure 54. LIT-Orbitrap-MS/MS Spectrum of a Dynein-Derived Peptide Found to be Labeled with 
TG1 
One of the several MS/MS spectra demonstrating a derived peptide sequence from the difference in m/z 
from the b and y ions.  Methionine is detected with a monooxygenation (*), while a cysteine is detected with an 
increase of 379 Da, indicating the mass of TG1.  
 119 
 
Figure 55. ThioGlo1 Adducts Detected by MS/MS 
Potential modifications of the Cys-TG1 adduct detected by MS/MS due to several combinations of gaining 
H2O and losing CH3
 
OH.  
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Table 4. Comparison of Surface-Accessible Cysteines Detected by Mass Spectrometry and 
Computational Prediction 
Comparison of Surface Accessible Cysteines by 
Computation Mass Spectrometry 
— Cys1886 
— Cys1930 
Cys1947 Cys1947 
Cys1975 — 
Cys1997 — 
— Cys2637 
— Cys2710 
Cys2983 — 
Cys3087 Cys3087 
— *Cys3145 
— *Cys3323 
Cys3571 — 
— Cys3691 
— Cys3710 
Cys3806 — 
Cys3938 Cys3938 
Cys4168 — 
Cys4214 Cys4214 
Cys4284 — 
Cys4508 — 
Cys4538 — 
Cys4568 Cys4568 
Cys4642 — 
* Residues deleted from sequence during modeling  
 
5.2.3 Electron Microscopy 
Finally, electron microscopy can be used to provide detailed electron density maps that can be 
used in conjunction with the computational models predicted to generate a more accurate 
structural representation of the cytoplasmic dynein heavy chain 1 motor domain.  The 380 kDa 
purified construct of cytoplasmic dynein heavy chain 1 motor domain was initially evaluated by 
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negative stain electron microscopy.  After several attempts to purify the protein from a 
baculovirus/insect cell system (Figure 56) it was evident from the SDS-PAGE gels that other 
proteins were still associated with the desired cytoplasmic dynein protein after nickel affinity 
chromatography, but that purity improved through the use of size exclusion chromatography, 
although not thoroughly, to a degree that the cytoplasmic dynein band was the most dominant.    
 
Figure 56. SDS-PAGE Gel Electrophoresis of Hi5/Baculovirus Expression of 380 kDa Cytoplasmic Dynein 
Purity of cytoplasmic dynein fractions purified by nickel affinity column chromatography indicated the 
presence of many contaminants.  
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Figure 57. SDS-PAGE Gel of Cytoplasmic Dynein After Additional Purification  
Purity of cytoplasmic dynein fractions purified by size exclusion chromatography followed by centrifugal 
filtration indicated the removal of most of the contaminants from cytoplasmic dynein.  
 
Nonetheless, the protein fraction obtained from size exclusion chromatography that 
alluded to the purest sample (“Retentate - Fraction 1” Figure 57) was evaluated by negative stain 
electron microscopy in an effort to reach an improved structural model of cytoplasmic dynein’s 
motor domain than previously reported in the literature (Samso and Koonce, 2004).  Several 
different negative stains were tested to evaluate which would provide the highest image contrast 
(Figure 58).  In these images, several ring-like structures were seen using uranyl acetate, 
ammonium molybdate, and phosphotungstic acid.  Although uranyl acetate appeared to highlight 
more cytoplasmic dynein particles, the stain also made other smaller protein contaminants or 
buffer staining artifacts more apparent.  There were also what appeared to be potential side 
orientations of cytoplasmic dynein present, but this was difficult to assess given the large amount 
 123 
of background signal.  The latter two negative stains appeared to highlight cytoplasmic dynein 
more clearly, but yielded much fewer particles on the copper grids.  These issues rendered it 
difficult to obtain the large amounts of particles (~103–106) necessary for averaging and image 
reconstruction purposes (Frank, 2009).  
 
Figure 58. Negative Stain Electron Micrographs of 380 kDa Rat Cytoplasmic Dynein Fragment 
Cytoplasmic dynein on copper grids stained with A) uranyl acetate, B) phosphotungstic acid, and C) 
ammonium molybdate. Images were then acquired with an FEI Tecnai T12 electron microscope. 
 
 
Since negative stain EM images of cytoplasmic dynein expressed from a Dictyostelium 
discoideum (slime mold) construct have been recently reported in the literature (Roberts et al., 
2009), we were interested in isolating native protein from a mammalian source that was perhaps 
less contaminated than the previous purification attempts and/or perhaps be in complex with its 
accessory proteins (dynactin, immunophilins, Hsps, etc.) (Pratt et al., 2004).  The tubulin 
purification protocol (Hamel and Lin, 1984) routinely employed in the Day lab was an ideal 
starting point to isolate cytoplasmic dynein.  Since the isolation protocol relies on consecutive 
MT polymerization and depolymerization steps to remove the various MAPs, each of the steps 
performed during the isolation protocol were analyzed by gel electrophoresis (Figure 59) in order 
to determine the fraction(s) in which cytoplasmic dynein was most abundantly present.  A 
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number of gel bands were then excised, digested with trypsin, and then analyzed by MALDI-
TOF-MS and -MS/MS to identify the proteins.   
 
Figure 59. SDS-PAGE Gel from Tubulin Isolation Protocol 
Individual steps from bovine brain tubulin isolation procedure were used to identify where cytoplasmic 
dynein would be most abundant.  Boxed gel bands were excised and digested with trypsin and peptide extracts were 
identified by MS/MS.  
 
 
As expected, cytoplasmic dynein heavy chain 1 was identified as the high molecular 
weight bands (Table 5).  In addition, heat shock cognate 70 (hsc70), a homolog of hsp70 from a 
gel band near 70 kDa was identified, which is often a companion of cytoplasmic dynein 
(Giannakakou et al., 2000).  Moreover, the microtubule-associated protein MAP2 (200 kDa), 
medium neurofilaments (100 kDa), light chain neurofilaments (62 kDa), and tubulin (50 kDa) 
co-purified with cytoplasmic dynein heavy chain were also identified.  These results were 
consistent with proteins expected to be isolated from bovine brain.  In particular, MAP2 has been 
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previously reported to stabilize MT formation and has been shown to link MTs to IFs or other 
MTs in mammalian brains (Bloom and Vallee, 1983).   
Table 5. Protein Identification of Gel Bands by MALDI-TOF-MS and -MS/MS 
Gel 
Band Name 
Protein Mass 
(Da) 
Protein 
Pilot 
Score 
Percent 
Coverage 
1 Cytoplasmic Dynein Heavy Chain 1 532072 75 13 
2 Cytoplasmic Dynein Heavy Chain 1 531916 69 13 
3 Microtubule Associated Protein 2 199404 361 35 
4 Microtubule Associated Protein 2 199404 285 27 
5 Microtubule Associated Protein 2 199404 165 15 
6 Neurofilament Medium Peptide 103148 939 43 
7 Neurofilament Medium Peptide 103148 50 17 
8 Neurofilament Light Peptide 62608 635 62 
9 Heat Shock Cognate 71 kDa Protein 70761 440 43 
10 Tubulin Beta 2A 49875 702 57 
11 Tubulin Beta 2A 49875 743 51 
 
 Based on the intensity of the cytoplasmic dynein gel bands from the different stages of 
tubulin isolation and purification, it was determined that the “second warm supernatant” stage 
would provide a significant amount of cytoplasmic dynein with less tubulin present compared to 
any of the other protein isolation steps.  Because the proteins identified in Table 5 were present 
in the sample, it was necessary to further isolate cytoplasmic dynein from the protein mixture.  In 
an effort to remove MAP2, which is comparable in size to cytoplasmic dynein, the protein 
mixture was taken through two additional rounds of MT polymerization and depolymerization in 
the presence of GTP and PTX.  The MT mixture was allowed to polymerize once more and ATP 
was added to release cytoplasmic dynein from the MTs (Burgess et al., 2003) in order to separate 
the two by ultracentrifugation.  When aliquots from each of the individual steps were evaluated 
by gel electrophoresis, it was evident that cytoplasmic dynein was more concentrated, but there 
was still a large amount of the lower molecular weight proteins (Figure 59).  The ATP-released 
fraction of cytoplasmic dynein was then further subjected to size exclusion chromatography.  
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Even though the majority of the protein contaminants were removed as evident by the gel 
electrophoresis of collected size exclusion chromatography fractions (Figure 60), a protein band 
similar in size to cytoplasmic dynein was still present and was not separable even by applying a 
slow elution gradient during chromatography.  A faint band around 55 kDa also persisted, 
suggesting that tubulin heterodimers were still bound to the MTBD of cytoplasmic dynein.   
 
Figure 60. SDS-PAGE Gel of ATP-Released Cytoplasmic Dynein Fraction Purified by Size Exclusion 
Chromatography 
Fractions collected every 1 min from size exclusion chromatography show a relatively purified fraction of 
cytoplasmic dynein extracted from bovine brain compared to ATP-released cytoplasmic dynein.  
 
Regardless, the fractions with the most abundant amount of cytoplasmic dynein were 
concentrated and applied to EM grids for analysis.  As evident in Figure 61, there were several 
ring-like structures representing the motor domain of cytoplasmic dynein.  In addition, there 
were several large helical polymers, which resemble structures previously reported to be formed 
by MAP2 (DeTure et al., 1996).  Preliminary results from the EM images of isolated cytoplasmic 
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dynein were not conclusive as to whether or not dynein was in the dimeric form, but a few motor 
domains appeared to be paired with minor electron densities connecting the two structures.  
 
Figure 61. Negative Stain Electron Micrographs of Bovine Cytoplasmic Dynein 
Bovine cytoplasmic dynein on copper grids stained with uranyl acetate. A) Several aggregates were present 
on the grids including the potential helical polymerization of MAP2. B) Individual cytoplasmic dynein particles 
were more present after size exclusion chromatography of samples. Images were then acquired with an FEI Tecnai 
T12 electron microscope. 
5.3 CONCLUSIONS 
Given the large size of cytoplasmic dynein, conventional biophysical tools such as X-ray 
crystallography and NMR cannot be applied to identify the large structure of cytoplasmic dynein.  
Therefore, a number of other methods including computational prediction and cysteine mapping 
were employed to evaluate the structure of cytoplasmic dynein heavy chain 1 motor domain.  
Based on the sequence alone, secondary structure and dihedral angle prediction suggested a 
predominantly α-helical structure, which was in agreement with previously proposed models.  
Ideally, prediction of secondary structure and dihedral angles should be performed using more 
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than one computational approach or algorithm for comparison purposes, but many of the 
programs were incapable of handling the long input sequence of the protein.  Disulfide bond 
connectivity prediction indicated the absence of disulfide bonds in the structure, which is 
possible given the reducing environment of the cytoplasm.  Comparative homology modeling of 
the cytoplasmic dynein heavy chain motor domain was generated using the Serihojis et al. 
(2006) model because it most resembled the electron density map of cytoplasmic dynein 
generated by cryo-electron microscopy (Mizuno et al., 2007).  Since the template was generated 
from crystal structures of proteins with high sequence homology to the domains of cytoplasmic 
dynein, several portions of the coordinates were missing and 999 residues from the input 
sequence were removed in order for a structural model to be generated.  Regardless, a structural 
model suggested the presence of 15 surface accessible cysteine residues.  Fluorescence 
spectroscopy measurements using the fluorescent tag TG1 indicated the presence of 6 surface 
accessible cysteine residues in the native state, while 15 additional residues were labeled in the 
presence of SDS.  Mass spectrometry was then applied to identify the TG1-labeled peptides, 
revealing 13 cysteines.  A comparison between the computationally predicted and experimentally 
determined surface accessible cysteine residues revealed 5 cysteines in agreement.  The 
remaining unmatched cysteines most likely suggests some inadequacy of the proposed structural 
model given the large number of residues removed from the sequence along with the lack of 
other AAA proteins with similar size to be used as additional templates.  Additional analysis of 
the mass spectral data in order to identify cysteines with other TG1 modifications than those 
suggested is necessary to evaluate if other cysteines correspond to those predicted from the 
computational model. 
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6.0  OVERALL CONCLUSIONS & FUTURE DIRECTIONS 
In summary, efforts were made to identify compounds that modulate the activity and characterize 
the structure of cytoplasmic dynein heavy chain 1.  An HCS cell-based nuclear translocation 
assay, previously employed in the Day and Johnston labs, were employed to identify cell-
permeable compounds that inhibited GR translocation mediated by cytoplasmic dynein.  Hits 
were further evaluated biochemically to identify the most likely target(s) of the compound 
resulting in inhibition of GR translocation.  High throughput assays were developed to screen for 
GR ligand competition and the ATPase activities of Hsp 70 and 90, cytoplasmic dynein heavy 
chain 1, and myosin.  Although a number of compounds were identified from the screening of 
the 1280 LOPAC library that inhibited cytoplasmic dynein, the non-specific characteristics of the 
apomorphines were unattractive for further studies.  Additional screening of the MLSCN 
collection appeared to highlight a number of compounds that specifically inhibited the ATPase 
activity of cytoplasmic dynein with little or no interaction with other proteins involved in cargo 
complex formation such as MLSCN compounds # 7, 19, 29, 64, 66, and 67.  Future work is 
necessary to perform concentration-dependent ATPase inhibition assays on these secondary hits 
to determine binding affinity and specificity.  Several of these compounds are already believed to 
have poor pharmacological or druggable characteristics such as the presence of nitric oxide and 
other sulfhydryl reactive moieties.  Therefore, synthetic chemistry approaches in conjunction 
with quantitative structure-activity relationship (QSAR) studies (Andrade et al., 2010) will assist 
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with the development of compounds with similar backbone structures and better 
pharmacological properties.   
A novel approach to screen for MT perturbing agents was also designed and implemented 
using biosensors.  Results from DPI followed the polymerization process of MTs on 
biotinylated-tubulin surfaces.  The process of MT polymerization was then implemented onto a 
similar RM biosensor surface using a cuvette-based setup in order to reduce sample consumption 
and increase throughput.  The initial rates of the polymerization process in the presence of MT 
perturbing agents was successfully used to distinguish MT stabilizers from destabilizers.  With 
current limited access to DPI and RM instruments, efforts were made to apply the same 
methodologies using an RWG biosensor.  With the availability of 96-, 384-, or 1536-well plates, 
more robust and rapid screening of MT perturbing agents compared to conventional turbidity 
assays may be conducted.  
The structure of the cytoplasmic dynein motor domain was then evaluated by a 
combination of computational and experimental methods.  Secondary structure and dihedral 
angle prediction both suggested that the structure of the motor domain was predominantly alpha-
helical, though the use of additional computational algorithms are needed to compare the validity 
of the proposed results.  Circular dichroism experiments, although complex with a protein of this 
size, could verify these results experimentally by approximating the ratio of secondary structure 
conformations of the protein (Provencher and Gloeckner, 1981).  Comparative homology 
structural modeling has allowed for prediction of surface accessible residues, specifically 
cysteine residues, which were correlated experimentally by MS.  Five cysteines were matched 
computationally and experimentally to be surface-accessible.  The remaining eight 
experimentally-detected reactive cysteines could also correlate with many of the other surface-
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accessible cysteines predicted computationally by additional experiments with smaller alkylating 
reagents.  Detection of the entire amino acid sequence is also necessary for a thorough 
correlation between computational and experimental results.  The current low correlation 
between computational and experimental results suggests that the proposed computational model 
has some inadequacies since only 1/3 (5 out of 15) of proposed cysteines matched between the 
two techniques.  Chemical crosslinking with certain affinity tags of cysteines may also provide 
another avenue for determining surface accessible cysteine residues while also providing Cys-
Cys distances within the structure (Sinz, 2003).  Pairwise cysteine mutagenesis along with EPR 
spectroscopy of attached spin labels will also allow for distance measurements within the 
structure (Schiemann and Prisner, 2007). 
Finally, negative stain EM was used to evaluate the structure of cytoplasmic dynein.  
Several ring-like structures were visible indicating the motor domain of cytoplasmic dynein. 
Most notably, the asymmetric electron density distribution of the motor domain resembled that 
of the proposed model.  Protein samples isolated from bovine brains appeared to have several 
paired rings that were in complex.  Attempts to construct a model of cytoplasmic dynein from 
electron microscopy images were hindered by the difficulties encountered in protein purification 
of both Hi5/baculovirus-expressed rat cytoplasmic dynein heavy chain 1 and protein isolated 
from bovine brain, although the latter appeared to provide better quality samples.  Ion exchange 
chromatography was of interest as a method to separate non-specific proteins during the protein 
purification, but was limited at the time by the availability of a column suitable for the molecular 
weight of cytoplasmic dynein.  Modifications in the protein purification of isolated protein, 
including perhaps expressing a protein with two distinct affinity moieties to reduce non-specific 
association of contaminants, should also be explored.  Once a purer sample is produced, many 
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dynein particles should be selected by negative stain EM followed by cryo-EM for structure 
reconstruction.  Once an electron density map of the protein is produced, the computational 
model along with information from the surface accessible cysteines determined experimentally 
will assist with the refinement of a structural model into the electron density map as suggested by 
Alexander et al. (2008). 
Ultimately, the structural characterization of cytoplasmic dynein plays an important role 
in the discovery of compounds that specifically bind to and modulate cytoplasmic dynein 
activity.  Similarly, compounds that “lock” dynamic cytoplasmic dynein into a rigid structure 
may assist with structural characterization of the protein, especially with electron microscopy. 
Here, several biophysical and pharmacological approaches have been attempted to identify the 
structure of and compounds that modulate the activity of cytoplasmic dynein heavy chain 1.  
This process is clearly in the preliminary stages, but builds a strong foundation for future 
experiments to follow.   
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APPENDIX A 
A.1 LIST OF COMPOUNDS FROM LOPAC SCREEN 
Chemical structures of compounds from the LOPAC screen identified as GR 
translocation inhibitors 
Compound Chemical Structure 
4-Phenyl-3-furoxancarbonitrile 
 
Parthenolide 
 
Apomorphine 
 
6-Nitroso-1,2-benzopyrone 
 
Calcimycin 
 
GR-127935 
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Bay 11-7085 
 
 
A.2 LIST OF COMPOUNDS FROM MLSCN SCREEN  
Compounds identified from biochemical assays as an inhibitor >50% (highlighted in red) at 20 
µM for at least one of the potential targets associated with cytoplasmic dynein translocation or 
other non-specific motor proteins.  
Number PubChem SID Chemical Structure 
Percent Inhibition 
Dynein GR Myosin 
4 14737082 
 
58.7 ± 
18.5 
60.1 
± 
12.3 
5.7 ± 
9.9 
6 26725810 
 
56.9 ± 
4.0 
8.9 ± 
41.0 
19.9 ± 
12.8 
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7 14739323 
 
78.8 ± 
17.7 
4.1 ± 
45.8 
35.0 ± 
10.1 
10 14731075 
 
83.0 ± 
1.4 
-0.2 ± 
18.1 
58.3 ± 
7.9 
11 17513591 
 
53.8 ± 
6.1 
50.6 
± 7.0 
17.8 ± 
6.9 
17 17412566 
 
64.8 ± 
3.6 
63.4 
± 
13.5 
39.0 ± 
6.1 
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19 22414253 
 
76.2 ± 
14.9 
21.4 
± 
19.0 
43.2 ± 
5.4 
23 17507787 
 
75.1 ± 
15.9 
-64.6 
± 2.8 
22.6 ± 
8.1 
27 24817175 
 
80.7 ± 
8.2 
3.1 ± 
42.8 
-3.7 ± 
24.9 
29 22404816 
 
84.9 ± 
10.0 
-4.4 ± 
16.6 
0.6 ± 
6.3 
32 24805460 
 
58.6 ± 
21.3 
6.0 ± 
2.0 
43.7 ± 
16.3 
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57 14739918 
 
53.4 ± 
26.5 
8.3 ± 
9.1 
9.2 ± 
10.2 
62 26664802 
 
65.3 ± 
12.5 
8.3 ± 
14.4 
60.6 ± 
10.7 
64 26725671 
 
70.0 ± 
14.7 
14.9 
± 
37.8 
25.3 ± 
9.3 
65 14719329 
 
54.4 ± 
10.3 
26.9 
± 
24.1 
24.5 ± 
18.4 
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66 17504722 
 
74.6 ± 
6.0 
37.7 
± 
17.7 
17.0 ± 
18.8 
67 14732770 
 
72.4 ± 
10.6 
38.0 
± 9.0 
3.7 ± 
20.9 
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APPENDIX B 
SEQUENCE COVERAGE OF CYTOPLASMIC DYNEIN BY MS AND MS/MS 
B.1 SEQUENCE COVERAGE FROM LC-MS/MS OF TRYPSIN DIGEST OF 
CYTOPLASMIC DYNEIN 
Sequence of rat cytoplasmic dynein heavy chain 1 with identified peptides highlighted in green 
with 56.53% sequence coverage.  
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B.2 SEQUENCE COVERAGE FROM LC-MS/MS OF TRYPSIN DIGEST OF 
CYTOPLASMIC DYNEIN LABELED WITH TG1 
Sequence of rat cytoplasmic dynein heavy chain 1 with identified peptides highlighted in green 
with 56.53% sequence coverage.  
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APPENDIX C 
MS/MS SPECTRA OF TG1-LABELED PEPTIDES 
Below are the MS/MS b (red) and y (blue) ions of peptides containing TG1-labeled cysteines.  
Shown above each spectrum is the sequence identity followed by the mass of the detected label 
(365, 379, 383, 397 Da).  Also included is the charge of the parent monoisotopic ion and the 
calculated mass of the peptide.  Retention time (RT) of eluted peptide and statistical information 
(cross correlation score (XCorr), probability, and number of ions matched) are also provided.  
(“?” = + charge)  
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